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Abstract 
 
Characterization of the Airway Epithelial Bioelectric Mechanisms Associated with the 
Effects of Epithelium-Derived Relaxing Factor in Guinea-Pig Isolated Trachea 
 
Richard A. Johnston 
 
In response to elevated serosal or mucosal tonicity, guinea-pig tracheal epithelium 
releases the non-nitric oxide, non-prostanoid, epithelium-derived relaxing factor (EpDRF), which 
subsequently diffuses to the underlying airway smooth muscle to initiate relaxation.  
Hypertonicity-induced smooth muscle relaxation via EpDRF involves epithelial Na+ and Cl! 
channels and is preceded by a depolarization of the transepithelial potential difference (Vms).  By 
utilizing two different experimental systems, this study sought to characterize further the airway 
epithelial bioelectric mechanisms associated with the effects of EpDRF in guinea-pig isolated 
trachea. 
 First, this study attempted to elucidate which epithelial ion channels and/or transporters 
are involved in the depolarization of the Vms.  This was accomplished by determining the effect 
of ion channel and transporter inhibitors on in vitro transepithelial short-circuit current responses 
to elevated mucosal tonicity in guinea-pig tracheal segments mounted in Ussing chambers.  The 
data from these studies indicate that apical Na+ channels and the basolateral Na+-K+-2Cl! 
cotransporter are intimately involved in the epithelial bioelectric response to elevated mucosal 
tonicity, and thus, may play an important role in the synthesis, release, and/or effects of EpDRF. 
 Secondly, this study sought to determine the consequences of altered epithelial ion 
transport, following LPS-treatment (4 mg/kg, i.p.; 18 hr post-treatment), on EpDRF-induced 
smooth muscle relaxation and its associated bioelectric events as well as airway reactivity to 
methacholine (MCh).  In vitro tracheal smooth muscle contractile and relaxant responses as well 
as Vms responses were measured utilizing the isolated and modified isolated, perfused trachea 
apparatuses while the two-chambered, whole-body plethysmograph was used to measure in vivo 
airway reactivity.  LPS-treatment caused numerous and complex changes in EpDRF-induced 
smooth muscle relaxation and its associated bioelectric events.  In addition, LPS-treatment 
causes in vivo airway hyporeactivity to MCh.  These results suggest that the effects of EpDRF on 
smooth muscle reactivity are modulated by changes in the electrical activity of the epithelium 
which can ultimately impact on airway reactivity to MCh. 
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The Mammalian Respiratory System 
 The mammalian respiratory system is comprised of the lungs, the extra- and 
intrapulmonary airways, the chest wall, and the respiratory control centers of the central nervous 
system (Levitzky, 1995).  The primary function of the respiratory system is to exchange gases 
between the atmosphere and the blood.  This ensures that mammals are supplied with oxygen 
while carbon dioxide is removed (West, 1995; Johnson, 1997).  Oxygen, in conjunction with 
other organic molecules, is utilized by the cell to produce energy in the form of adenosine 
triphosphate during the process of oxidative phosphorylation (Lehninger et al., 1993).  Aside 
from gas exchange, the respiratory system has non-respiratory functions which include playing a 
significant role in (1) acid-base balance, (2) body defense, (3) metabolism, (4) olfaction, (5) 
phonation, and (6) water loss (Levitzky, 1995). 
 In order for cells to be supplied with oxygen, the oxygen within the inspired air must first 
gain access to the alveoli, or gas exchanging regions of the lung, before being distributed 
throughout the body by means of the circulatory system.  Air is primarily inspired through the 
nose and to a lesser extent, the mouth, and once inspired, it passes through the pharynx, larynx, 
trachea, bronchi, and bronchioles until it eventually reaches the alveoli.  The most distal portion 
of the trachea branches into right and left primary bronchi which enter the right and left lungs, 
respectively.  The right and left primary bronchi continue to branch even further into at least two 
smaller daughter branches.  The airways continue to branch until terminating into alveolar sacs 
(Weibel, 1963; Nagaishi et al., 1972; Curtis and Barnes, 1989; Sherwood, 1997).  Figure 1 
illustrates the branching of the tracheobronchial tree, and because of anatomical and functional 
differences along its length, it is divided into a conducting zone and a respiratory or transitional 
zone.  The conducting zone consists of airway generations zero to sixteen while generations 
seventeen to twenty-three make up the respiratory or transitional zone (Weibel, 1963). 
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 Gas exchange is restricted to the respiratory or transitional zone while the conducting 
zone constitutes an anatomic dead space (Levitzky, 1995).  When air moves through the 
conducting airways, it is humidified and warmed to body temperature 
(Levitzky, 1995; Sherwood, 1997).  The respiratory or transitional zone occupies the last 5 mm 
of each airway branch and consists of small airways, namely bronchioles and alveoli, which are 
capable of gas exchange (Bouhuys, 1977).  In addition to the functional differences between the 
conducting and respiratory or transitional zones, there is also a great deal of structural 
heterogeneity in the airways within and between these two regions. 
 The airways of the upper conducting zone are relatively nonmuscular, rigid tubes 
encircled by cartilaginous rings.  Their walls are rich in connective tissue and cartilage but 
sparsely populated with smooth muscle (Johnson, 1997).  The luminal surface of these airways 
are predominately lined with ciliated, pseduostratified, columnar epithelial cells, among which 
are dispersed submucosal glands, basal, brush, goblet, Kulchitsky, and serous cells as well as a 
small number of neuroendocrine cells 





Figure 1.  Divisions of the tracheobronchial tree.  Z, generation; BR, bronchus; BL, bronchiole; 
TBL, terminal bronchiole; RBL, respiratory bronchiole; AD, alveolar duct; AS, alveolar sac.  
Reprinted with permission from Weibel ER (1963) Morphometry of the Human Lung, Academic 
Press Ltd, London UK. 
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The airways located at the junction between the conducting and respiratory or transitional zones 
differ from those either proximal or distal to them.  Their walls are devoid of cartilage and 
contain little connective tissue but are rich in smooth muscle (Weibel, 1963; Nagaishi et al., 
1972; Johnson, 1997).  Ciliated, cuboidal epithelial cells are the predominant epithelial cell type 
of this region; however, they are smaller than their more proximal counterparts.  There are fewer 
goblet cells in this region while submucosal glands are virtually absent.  Clara cells, secretory 
cells of ambiguous function, also populate this region 
(Divertie and Brass, 1980; Fawcett and Jensh, 1997; Johnson, 1997).  The differences in 
epithelial cell morphology within the conducting zone are shown in Figure 2. 
 The airway walls of the respiratory or transitional zone lack smooth muscle and contain 
very little connective tissue (Johnson, 1997).  Type I alveolar epithelial cells are the predominant 
cell type covering the luminal surface of the alveoli.  They are long, thin cells lacking cilia.  
Type II alveolar epithelial cells, which synthesize and secrete surfactant, are also found, to a 
lesser extent, along the luminal surface of the alveoli (Sherwood, 1997).  In order for gas 
exchange to occur between the alveoli and the blood in the pulmonary capillaries, the gas must 
diffuse through the air-blood barrier which is formed by the pulmonary capillary endothelium, 
the type I alveolar epithelium, and the interstitial space between the two (Sherwood, 1997).  An 
illustration of the air-blood barrier is shown in Figure 3.  There are an estimated 300 million 
alveoli and nearly 1000 pulmonary capillaries surrounding each alveolus, providing a 50-100 m2 
surface area for gas exchange (Divertie and Brass, 1980; West, 1995).  When this is taken with 
the fact that the air-blood barrier is only 0.5 µm thick, the mammalian respiratory system is 









Figure 2.  Epithelial cell morphology of the (A) proximal and (B) distal airways of the 
conducting zone. Along the respiratory tract, there are distinct differences in epithelial cell 
morphology.  Copyright 1980. Novartis.  Reprinted with permission from Novartis Medical 





Figure 3.  The air-blood barrier.  This illustration depicts two of an estimated 300 million 
alveoli, the gas exchanging regions of the lung, and the other, affiliated structures of the air-
blood barrier.  Copyright 1980.  Novartis.  Reprinted with permission from Novartis Medical 
Education, illustrated by Frank H. Netter, MD.  All rights reserved. 
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The Respiratory Smooth Muscle and Its Neural Innervation 
 The respiratory or airway smooth muscle is one of the six basic types of smooth muscle 
(Horowitz et al., 1996).  It has many structural features in common with the other types of 
smooth muscle and is found from the trachea to the respiratory bronchioles, albeit in different 
quantities. 
 The parasympathetic nervous system has a profound impact on airway smooth muscle 
contraction.  Postganglionic parasympathetic fibers directly innervate the smooth muscle.  The 
release of acetylcholine (ACh) from these neurons initiates smooth muscle contraction via 
smooth muscle M3 cholinoceptors which are coupled to Gq-proteins on the muscle cells.  Other 
spasmogens, by binding to their appropriate receptors, also initiate smooth muscle contraction 
through the activation of Gq-proteins.  The "q subunit of the Gq-protein activates the inner, 
plasma membrane-bound enzyme phospholipase C-$, leading to the synthesis of inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol from a membrane-bound phospholipid, 
phosphatidylinositol 4,5 bisphosphate.  IP3 elevates cytosolic Ca2+ levels by stimulating, either 
directly or indirectly, the release of Ca2+ from intracellular stores (sarcoplasmic reticulum and 
mitochondria), the influx of extracellular Ca2+ through Ca2+-selective ion channels and/or 
transporters, and Ca2+-induced Ca2+ release.  Elevations in cytosolic Ca2+ activate the 
Ca2+/calmodulin-dependent myosin light chain kinase which enhances actin-myosin interactions 
resulting in smooth muscle contraction (Figure 4A) (Gross, 1988; Allen and Walsh, 1994; 
Horowitz et al., 1996; Janssen et al., 1998). 
 The sympathetic nervous system can also influence airway smooth muscle tone.  There is 
evidence that postganglionic sympathetic fibers terminate on postganglionic parasympathetic 
nerves, thereby having the capability to modulate cholinergic neural mechanisms 
(Ind and Barnes, 1988). Activation of smooth muscle $2-adrenoceptors by adrenergic agonists 
initiates bronchodilation by activating adenylate cyclase which increases intracellular cyclic 
adenosine monophosphate (cAMP) levels.  cAMP stimulates smooth muscle relaxation by down-
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regulating myosin light chain kinase activity, stimulating the uptake of Ca2+ into the 
sarcoplasmic reticulum, and activating Ca2+-dependent K+ channels (Figure 4B) 
(Kotlikoff and Kamm, 1996; Janssen et al., 1998). In humans, prostaglandin E2 is capable of 
elevating intracellular smooth muscle cAMP concentrations and initiating relaxation.  "-
Adrenoceptors are also present on airway smooth muscle, but the consequences of their 
activation are more controversial (Ind and Barnes, 1988). 
 Besides the autonomic nervous system, there are other neural systems capable of 
modulating airway smooth muscle tone.  The inhibitory nonadrenergic, noncholinergic (i-
NANC) system is the only significant bronchodilator pathway in humans.  Vasoactive intestinal 
peptide (VIP) and nitric oxide (NO) are the major neurotransmitters of this system 
(Barnes, 1988).  VIP exerts its bronchodilating effects by elevating intracellular cAMP levels 
while NO initiates bronchodilation by activating soluble guanylate cyclase, resulting in the 
activation of smooth muscle K+ channels via cyclic guanosine monophosphate (cGMP) (Figure 
4B) (Janssen et al., 1998).  The excitatory nonadrenergic, noncholinergic (e-NANC) system is 
another neural system capable of influencing airway smooth muscle tone.  e-NANC fibers 
release substance P and tachykinins from their terminals located beneath the airway epithelium.  
Both substance P and tachykinins initiate smooth muscle contraction by activation of their 












Figure 4.  Mechanisms of airway smooth muscle (A) contraction and (B) relaxation.  See text for 
details.  ACh, acetylcholine; G, G-protein-coupled receptor; PLC, phospholipase C-$; IP3, 
inositol 1,4,5-trisphosphate; )V, change in membrane potential:  (A) depolarization and 
(B) hyperpolarization; NE, norepinephrine; PGE2, prostaglandin E2; NO, nitric oxide; AC, 
adenylate cyclase; GC, soluble guanylate cyclase; cAMP, cyclic adenosine monophosphate; 
cGMP, cyclic guanosine monophosphate.  Reprinted with permission from Janssen LJ, Daniel 
EE and Rodger IW (1998) Airway smooth muscle cells:  Structure and function, in Asthma:  
Basic Mechanisms and Clinical Management (Barnes PJ, Rodger IW and Thomson NC eds) pp 
90-112, Academic Press Ltd, London UK. 
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The Respiratory Epithelium 
 The respiratory or airway epithelium constitutes a barrier to control the movement of 
substances between the external and internal environments of the body 
(Hulsmann and Jongste, 1996; Fawcett and Jensh, 1997); however, the epithelium functions as 
more than just a simple diffusion barrier (Widdicombe, 1991; Folkerts and Nijkamp, 1998).  
Under normal physiological conditions, the respiratory epithelium also functions as a mucus 
transporter (Widdicombe, 1991; Clarke and Boucher, 1993), a regulator of ion and fluid transport 
(Clarke and Boucher, 1993; Boucher, 1999), an osmotic sensor 
(Willumsen et al., 1994; Dortch-Carnes et al., 1999; Fedan et al., 1999), a site of metabolism for 
both endogenous and exogenous substances, and a source of spasmogenic and relaxant 
substances which are capable of modulating the reactivity of the underlying airway smooth 
muscle 
(Flavahan et al., 1985; Fedan et al., 1988; Goldie and Hay, 1997; Folkerts and Nijkamp, 1998). 
 Overlying the luminal or mucosal surface of the respiratory epithelium is the airway 
surface liquid (ASL) which consists of two layers:  the sol and the gel.  The sol layer is a thin, 5 
to 7 µm in depth, watery layer which blankets the surface.  Its thickness approximates the length 
of the cilia extending from the luminal surface of the epithelium.  The gel layer rests upon the sol 
layer and is a discontinuous mucus blanket, consisting of 95% water (Figure 5).  Since the mucus 
is both elastic and viscous, it can easily trap, and subsequently hold, inhaled, foreign matter.  As 
the cilia beats, both the sol and gel layers move in tandem in a cephalad direction which allows 
for the effective clearance of inhaled, foreign substances and microorganisms from the 
respiratory tract.  Epithelial ion and fluid transport play a major role in determining the depth of 







Figure 5.  Airway surface liquid (ASL).  The ASL blankets the mucosal surface of the airway 
epithelium and consists of two layers:  the sol and the gel.  The depth of the ASL ranges between 
5-100 µm (Widdicombe and Widdicombe, 1995).  Reprinted from Clarke LL and Boucher RC 
(1993) Ion and water transport across airway epithelia, in Pharmacology of the Respiratory 
Tract:  Experimental and Clinical Research (Chung KF and Barnes PJ eds) pp 505-550 by 
courtesy of Marcel Dekker Inc.  For clarity, the author of this dissertation added the figure labels. 
12 
 Under normal, physiological conditions, the epithelium of the conducting airways of 
most mammalian species, excluding the cow and the dog, is Na+-absorbing (Boucher et al., 1982; 
Langridge-Smith et al., 1984); however, all generate a lumen-negative potential with respect to 
the basolateral surface.  A tentative localization of airway epithelial ion channels and transporters 
is shown in Figure 6.  The activity of the Na+-K+-ATPase, localized to the basolateral surface of 
the epithelial cell, establishes an electrochemical gradient which draws Na+ into the cell from the 
ASL through amiloride-sensitive Na+ channels.  The Na+ is then extruded from the cell across 
the basolateral membrane by means of the Na+-K+-ATPase.  K+ channels and the electroneutral 
Na+-K+-2Cl! cotransporter also play a role in epithelial ion transport.  Under normal, 
physiological conditions for most mammalian species, there is no net transcellular movement of 
Cl!; however, in order to achieve electrochemical equilibrium, Cl! moves through the 
paracellular pathway as Na+ is absorbed transcellularly (Figure 6) 
(Boucher et al., 1982; Clarke and Boucher, 1993; Knowles et al., 1995). 
 
Epithelium-Derived Relaxing Factor 
 The respiratory epithelium can synthesize and release substances which are capable of 
diffusing to the underlying airway smooth muscle and modulating its tone 
(Fedan et al., 1988; Morrison et al., 1990; Hulsmann and Jongste, 1996).  These autacoids can 
have either an excitatory or inhibitory effect upon airway smooth muscle tone.  The inhibitory, 
non-nitric oxide, non-prostanoid epithelium-derived relaxing factor (EpDRF) is one such 
autacoid (Munakata et al., 1988, 1990; Fedan et al., 1999). 
In 1985 Flavahan and colleagues provided the first evidence that the respiratory 
epithelium could modulate the tone of the underlying airway smooth muscle.  After mechanical 
removal of the epithelium from canine bronchial rings, the bronchial smooth muscle became 









Figure 6.  Distribution of airway epithelial ion channels and transporters and the major ion 
transport processes of the airway epithelium.  This illustration holds true for most mammalian 
species (Boucher et al., 1982; Clarke and Boucher, 1993).  The various ion channels and 
transporters of the airway epithelium are asymmetrically distributed between the apical and 
basolateral surfaces of these cells.  The respective inhibitor of each ion channel and transporter is 
shown in parentheses.  The arrows indicate the net, transcellular movement of Na+ and the 
passive, paracellular movement of Cl! (illustration produced by and courtesy of Jeffrey S. Fedan, 
Ph.D.). 
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In canine bronchial rings precontracted with ACh, isoproterenol-induced relaxations were 
 attenuated in epithelium-denuded preparations.  This same study also demonstrated that 
contractile responses to transmural nerve stimulation were potentiated by epithelium removal.  In 
epithelium-intact preparations, the peak contraction elicited by a particular electrical frequency 
was followed by a decrease in tone as the stimulation continued; however, this decrease in tone 
was absent in epithelium-denuded preparations (Flavahan et al., 1985).  Later that same year, a 
separate group reported that epithelium removal increased the sensitivity of bovine tracheal strips 
to the contractile effects of ACh, histamine, and 5-hydroxytryptamine (Barnes et al., 1985).  In 
the months and years that followed, other studies with isolated, human (Raeburn et al., 1986a), 
guinea pig (Hay et al., 1986; Holroyde, 1986; Murlas, 1986), and rabbit (Raeburn et al., 1986b) 
airway preparations reported that epithelium removal increased the sensitivity of the airway 
smooth muscle to contractile agonists; however, the effect of epithelium removal upon airway 
smooth muscle reactivity to relaxant agonists was much more variable.  Most of these studies, 
with the exception of Holroyde (1986) concluded that the increased sensitivity of the smooth 
muscle to contractile agonists following epithelium removal was due to the loss of an epithelium-
derived inhibitory factor, EpDRF, which normally inhibits smooth muscle reactivity to 
contractile agonists.  Some of these same studies also demonstrated that EpDRF was not a 
metabolite of arachidonic acid (Barnes et al., 1985; Flavahan et al., 1985), but nevertheless, a 
separate study concluded that the cytochrome P450 enzyme system was involved in epithelial 
modulation of smooth muscle tone (Raeburn et al., 1988). 
 The first evidence supporting the hypothesis that the airway epithelium releases an 
inhibitory factor capable of modulating the reactivity of adjacent smooth muscles came in 1986 
with the development of the coaxial bioassay preparation.  This preparation consisted of an 
endothelium-denuded rabbit aortic strip (recipient tissue) positioned within the lumen of an 
epithelium-intact or -denuded guinea-pig trachea (donor tissue) (Figure 7A).  By attaching the 
endothelium-denuded rabbit aortic strip to an isometric force transducer, contractile and relaxant 
responses of this tissue could be measured.  Following the contraction of the aortic strip with 
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phenylephrine, an "1-adrenoceptor agonist, ACh was added to the preparation which 
subsequently relaxed the aortic strip.  When the epithelium was removed from the guinea-pig 
trachea, and the same experiment repeated, the aortic strip failed to relax (Ilhan and Sahin, 1986) 
(Figure 7B).  Coaxial bioassay experiments from other laboratories reported similar results when 
guinea-pig tracheal smooth muscle or rat anococcygeus muscle were used as the recipient tissue 
(Güc et al., 1988a; Güc et al., 1988b), or when human bronchus was used as a donor to relax 
phenylephrine-contracted rat aortic strips (Fernandes et al., 1990).  In all of these coaxial 
bioassay experiments, as in the original, removal of the epithelium from the donor tissue 
abolished the relaxation response of the recipient tissue, supporting the notion that the relaxation 
of the recipient tissue was dependent upon an epithelium-derived relaxing factor, EpDRF.  
Further pharmacological characterization of EpDRF with the coaxial bioassay preparation 
demonstrated that this factor was not a product of nitric oxide synthase, cyclooxygenase, 
lipoxygenase, or the cytochrome P450 enzyme systems.  This same study showed that EpDRF 
was not related to free radical production, soluble guanylate cyclase, $-adrenoceptors, or 
platelet-activating factor (Fernandes and Goldie, 1990). 
 Until the late 1980s, EpDRF was studied using rings or strips of airway tissue, which had 
limited usefulness.  In 1988 the guinea-pig isolated, perfused trachea apparatus was developed, 
allowing for much more elegant EpDRF studies (Munakata et al., 1988).  This preparation 
allowed pharmacological agents to be added separately to either the extraluminal (serosal) or 
intraluminal (mucosal) surfaces of the trachea.  In this preparation, contractile agonists added to 
the extraluminal surface were more potent since they had direct access to the smooth muscle.  
Agents added to the intraluminal surface must first diffuse through the epithelium before 
interacting with the smooth muscle. Early experiments with this preparation (Munakata et al., 
1988) demonstrated that increasing the tonicity of the solution perfusing the intraluminal surface 







Figure 7.  Coaxial bioassay preparation.  (A) A diagram of the coaxial bioassay preparation 
whose use was first reported by Ilhan and Sahin in 1986.  (B) A schematic illustration of the 
experimental results obtained from this preparation.  The addition of ACh to an endothelium-
denuded, phenylephrine (PE)-contracted, rabbit aortic strip within an epithelium-intact (+Epi), 
guinea-pig trachea relaxed the aortic strip.  When the same experiment was repeated using an 
epithelium-denuded (-Epi), guinea-pig trachea, the aortic strip failed to relax; thus, the ability of 
the epithelium to produce a transferrable EpDRF was concluded (illustration produced by and 
courtesy of Jeffrey S. Fedan, Ph.D.). 
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When hypertonic solutions of NaCl, KCl, urea, or mannitol were added to the intraluminal 
surface of a carbachol-contracted trachea, the smooth muscle relaxed.  When the experiment was 
repeated in epithelium-denuded trachea, smooth muscle relaxation was significantly attenuated, 
demonstrating that the relaxation response evoked by hypertonic solution was epithelium-
dependent (Munakata et al., 1988).  A separate study later demonstrated that increasing the 
tonicity of the extraluminal surface of the trachea also stimulated EpDRF-induced smooth 
muscle relaxation (Fedan et al., 1999).  It has also been shown that stimulating the release of 
EpDRF with hypertonic solution decreased smooth muscle reactivity to methacholine and 
transmural nerve stimulation (Fedan et al., 1999).  Although it has been shown that elevated 
extraluminal and intraluminal tonicity elicit epithelium-dependent smooth muscle relaxation via 
EpDRF, EpDRF’s mechanism of action as well as its identity remains largely obscure. 
 It has been demonstrated clearly that EpDRF-induced smooth muscle relaxation, evoked 
by hypertonic solution, is unaffected by nitric oxide synthase inhibitors, indomethacin, 
methylene blue, propranolol, and tetrodotoxin (Munakata et al., 1988, 1990; Fedan et al., 1999).  
Interestingly, gossypol, a dual cyclooxygenase-lipoxygenase inhibitor and oxygen radical 
scavenger, and hemoglobin attenuate relaxation responses to elevated intraluminal tonicity 
(Teeter et al., 1988; Munakata et al., 1990; Fedan and Johnston, unpublished).  Because 
hemoglobin, and not nitric oxide synthase inhibitors, attenuates EpDRF-induced smooth muscle 
relaxation, this suggests that carbon monoxide may play a role in the relaxation response to 
elevated tonicity since carbon monoxide is capable of binding to hemoglobin (West, 1995). 
 Previous work has suggested that the synthesis, release, and/or effects of EpDRF may be 
functionally linked to the electrical activity of epithelial cells (Raeburn and Fedan, 1989).  Fedan 
et al. (1999) reported that amiloride-sensitive Na+ channels and 4-4'-diisothiocyanatostilbene-2-
2' disulfonic acid (DIDS)-sensitive Cl! channels seem to be involved in EpDRF-induced smooth 
muscle relaxation.  Both amiloride and DIDS attenuate EpDRF-induced smooth muscle 
relaxation responses elicited by elevated intraluminal tonicity.  Fedan et al. (1999) also reported 
that the Na+-K+-2Cl! cotransporter and the Na+-K+-ATPase play virtually no role in EpDRF-
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induced smooth muscle relaxation.  A separate study reported that epithelial Ca2+-activated K+ 
channels may be involved in the synthesis and/or release of EpDRF (Tamaoki et al., 1997).  
Dortch-Carnes et al. (1999) recently modified the isolated, perfused trachea apparatus to measure 
transepithelial potential difference simultaneously with smooth muscle contraction and 
relaxation.  This modified preparation has provided more evidence that the synthesis, release, 
and/or effects of EpDRF are functionally linked to epithelial electrical activity. Dortch-Carnes et 
al. (1999) have reported that depolarization of the transepithelial potential difference precedes 
EpDRF-induced smooth muscle relaxation elicited by elevating intraluminal tonicity with either 
ionic or non-ionic osmolytes (Dortch-Carnes et al., 1999).  A summary of EpDRF’s actions are 
illustrated in Figure 8. 
 
Cell-Volume Regulation in Response to Hypertonic Challenge 
 When exposed to anisotonic solutions, cells activate volume regulatory mechanisms to 
either maintain or return to their normal volume 
(Parker, 1993; McManus et al., 1995; Haüssinger, 1996). When the tonicity of the mucosal and 
serosal surfaces of the airway epithelium are elevated, this is a major stimulus for the synthesis, 
release, and/or effects of EpDRF (Munakata et al., 1988; Fedan et al., 1999), it is therefore 
essential to understand the principles of cell-volume regulation as they pertain to hypertonic 
challenge.  A cell loses water when exposed to a hypertonic environment.  In order to regain its 
normal volume, the cell activates regulatory volume increase (RVI) mechanisms.  Increases or 
decreases in cell volume can only be achieved by the gain or loss, respectively, of osmotically 
active solutes.  Osmotically active solutes include inorganic ions such as Na+, K+, and Cl! and 
small, organic osmolytes.  These small, organic osmolytes are divided into three major classes:  
(1) amino acids and their derivatives (i.e., alanine, proline, and taurine), (2) methylamines (i.e., 
betaine and glycerylphosphorylcholine), and (3) polyols (i.e., sorbitol and myo-inositol).  These 
molecules are sometimes referred to as non-perturbing osmolytes since the cell can accumulate 
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high concentrations of these substances without deleterious effects on cell structure and function 
(McManus et al., 1995; Lang et al., 1998).  RVI mechanisms occur in two steps.  First, within 
seconds after exposure to a hypertonic environment, a cell increases its net gain of Na+ and Cl! 
to maintain its volume through activation of the Na+-K+-2Cl! cotransporter and the Na+-H+ 
exchanger, both of which are present on airway epithelial cells.  Because the intracellular pH is 
altered by the activity of the Na+-H+ exchanger, there is subsequent activation of the Cl!-HCO3! 









Figure 8.  Actions of the airway epithelium-derived relaxing factor (EpDRF).  EpDRF is known 
to be released when the tonicity of either the apical or basolateral surfaces of the airway 
epithelium are elevated, which in this illustration is denoted by NaCl.  Once released, EpDRF 
can relax the airway smooth muscle.  It is still questionable whether or not EpDRF can relax 
vascular smooth muscle or if it is capable of attenuating the effects of ACh released from 
postganglionic parasympathetic nerve terminals.  Epi, airway epithelium; VSM, vascular smooth 
muscle; ASM, airway smooth muscle; ACh, acetylcholine (illustration produced by and courtesy 
of Jeffrey S. Fedan, Ph.D.). 
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The second step involves the accumulation of small organic osmolytes by activating the 
transcription of genes encoding osmolyte synthetic enzymes and transporters (Figure 9).  These 
osmolytes are accumulated along with Na+ by means of Na+-coupled osmolyte transporters, and 
this process can last for hours or days (McManus et al., 1995; Lang et al., 1998).  In addition 
during RVI, cells breakdown cytoplasmic proteins while the anabolic pathways leading to the 
synthesis of organic osmolytes are increased (Haüssinger, 1996). 
 
Exercise-Induced Asthma 
 In general, asthma can be defined as a chronic, inflammatory airway disease 
characterized by reversible airway obstruction.  Asthma affects over 5% of the inhabitants of the 
world’s industrialized countries (Shelhamer et al., 1995; Barnes et al., 1998).  In the United 
States as many as twelve million persons may be afflicted with asthma (Shelhamer et al., 1995).  
The most common pathophysiological features of asthma include:  (1) sloughing and 
desquamation of the respiratory epithelium, (2) thickening of the respiratory epithelial basement 
membrane, (3) goblet cell hyperplasia, (4) submucosal gland enlargement, (5) airway smooth 
muscle hypertrophy and hyperplasia, (6) dilation of the bronchial vasculature, (7) airway edema, 
(8) recruitment of inflammatory cells into the airways (Jeffrey, 1998), 
and (9) nonspecific airway hyperreactivity to nonsensitizing physical or chemical stimuli 
(Cockcroft and O'Byrne, 1993). 
 Approximately 70-80% of asthmatics experience exercise-induced asthma (EIA) which is 
a general term used to describe a transient increase in airway resistance following strenuous 
exercise.  A decrease of 10% or more in the volume of air forcibly expired in one second (FEV1) 




Figure 9.  Mechanisms of regulatory volume increase (RVI).  The RVI mechanisms occur in two 
steps. First, immediately after cells shrink due to exposure to a hypertonic environment, cells 
accumulate inorganic ions, namely Na+ and Cl! through the activation of the Na+-K+-2Cl! 
cotransporter, the Na+-H+ exchanger, and subsequently the Cl!-HCO3! exchanger.  The second 
step occurs over many hours or days and involves the accumulation of organic osmolytes via the 
induction of genes encoding for osmolyte synthetic enzymes and ion-coupled transporters.  
5'•AAA3' represents elevations in mRNA levels to convey an up-regulation of the transcription 
of genes encoding osmolyte synthetic enzymes and ion-coupled transporters.  Figure adapted 
with permission from McManus ML, Churchwell KB and Strange K (1995) Regulation of cell 
volume in health and disease, N Engl J Med 333:1260-1266. 
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EIA is the most extreme five to ten minutes upon the cessation of exercise; however, a refractory 
period exists for up to three hours after the initial attack has ended 
(Anderson, 1985; McFadden, 1995).  In contrast to asthmatics who may experience 
bronchoconstriction following exercise, normal individuals may actually experience 
bronchodilation during exercise (Kagawa and Kerr, 1970).   Many hypotheses have tried to 
explain the phenomenon of EIA (Freed, 1995); however, two hypotheses in particular have 
gained the most attention:  (1) the thermal hypothesis of EIA and (2) the osmotic theory of EIA.  
Most of the experimental evidence seems to support the osmotic theory of EIA 
(McFadden, 1995; Anderson and Daviskas, 1999) which is described in the following 
paragraphs. 
 Because of temperature and water vapor concentration gradients, heat and water are 
added to the inspired air as it passes over the respiratory mucosa of the conducting airways, a 
process referred to as conditioning.  Under normal physiological conditions, most of the inspired 
air is conditioned by the time it reaches the oropharynx.  During strenuous exercise, an 
individual’s ventilation rate increases dramatically; therefore, the respiratory tract has to 
condition a greater volume of air over a much shorter period of time.  As a consequence, more 
airways are actively recruited to condition the inspired air, and in the process, the respiratory 
mucosa loses more heat and water than normal to the inspired air.  The ASL is the major source 
of water used to condition the inspired air during exercise.  The water lost from the ASL during 
exercise is not readily replaced, and as a result, the osmolarity of the ASL increases 
(Anderson and Daviskas, 1999). 
 The osmotic theory of EIA suggests that the increased ASL osmolarity results in the 
release of bronchoactive mediators from the epithelium, bronchial mucosal mast cells, and 
sensory nerves which lead to EIA.  Spasmogenic substances released from these cells include 
prostaglandin D2, leukotrienes, histamine, and substance P, all of which can readily diffuse to the 
smooth muscle and initiate bronchoconstriction.  Increasing the osmolarity of the ASL also leads 
to the release of bronchorelaxant substances from the airway epithelium, including NO, 
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prostaglandin E2, and EpDRF 
(Munakata et al., 1988; Anderson and Daviskas, 1999; Fedan et al., 1999).  The effects of airway 
drying on the airway epithelium and surrounding cells of the airway wall are illustrated in Figure 
10. 
 The osmotic theory of EIA explains why some asthmatics could experience 
bronchoconstriction following exercise whereas normal individuals do not.  In asthmatics, the 
airway epithelium is sloughed and desquamated (Laitinen et al., 1985), and as a consequence, 
more airways would have to be recruited to condition the inspired air.  This could lead to an 
increase in the ASL osmolarity throughout the respiratory tract, resulting in the release of 
bronchospastic mediators from various sources to initiate EIA (Anderson and Daviskas, 1999).  
In normal individuals, the intact epithelium may produce enough bronchorelaxant factors (NO, 









Figure 10.  The effects of airway drying on the airway epithelium and airway wall.  (A) The net 
direction of ion and water movement across the airway epithelium under normal, physiological 
conditions is indicated by the arrows.  (B) Evaporative water loss (airway drying) as a result of 
hyperpnea reduces the depth of the periciliary fluid or ASL and increases its concentration of 
inorganic ions; thus, its osmolarity is elevated.  This results in the release of bronchoactive 
mediators from the epithelium and the vascular endothelium of bronchial vessels in the airway 
wall.  These mediators are capable of diffusing to the airway smooth muscle and modulating its 
tone.  In addition, water movement from the submucosal tissues increases during this time in 
order to replenish the water lost from the periciliary fluid during airway drying.  PGs, 
prostaglandins; NO, nitric oxide.  Reprinted from Anderson SD and Daviskas E (1999) Airway 
drying and exercise-induced asthma, in Exercise-Induced Asthma (McFadden ER ed) pp 77-113 
by courtesy of Marcel Dekker Inc. 
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Lipopolysaccharide, Sepsis, and Acute Respiratory Distress Syndrome 
 Lipopolysaccharide (LPS) is an amphiphilic macromolecule which is the major 
component of the outer membrane of gram-negative bacteria (Figure 11A).  LPS consists of two 
major structural components:  a polysaccharide portion and a lipid A portion.  The lipid A 
component is covalently bound on one side to the outer membrane of the bacterium whereas the 
polysaccharide portion is bound to the other end of the lipid A component and extends into the 
extracellular space.  As Figure 11B illustrates, the polysaccharide portion can be further 
subdivided into a core region and an O-specific chain.  The lipid A portion is highly conserved 
among gram-negative bacteria and is the toxic component of the LPS macromolecule.  As gram-
negative bacteria die or begin to replicate, LPS is released and capable of initiating its 
pathological effects (Lüderitz et al., 1982; Rietschel et al., 1994, 1996; Raetz, 1996). 
 LPS, in itself, is not toxic, but it is the immunologic and inflammatory events that it 
initiates which are detrimental.  Various serum proteins are capable of modulating the effects of 
LPS, but the most important is the lipopolysaccharide-binding protein (LBP).  By binding to the 
LBP, the LPS macromolecule is delivered to a membrane-bound receptor, CD14, found on 
macrophages and monocytes, and once bound, LPS-induced signal transduction can commence 
(Rietschel et al., 1996). LPS stimulates a wide variety of cellular processes, some of which are 
summarized in Figure 12.  An overwhelming gram-negative bacterial infection can result in 










Figure 11.  Localization of lipopolysaccharide (LPS) and its chemical components.  (A) LPS is 
the major component of the outer membrane of gram-negative bacteria.  GluNAc, N-acetyl-D-
glucosamine; KDO, 3-deoxy-D-manno-octulosonic acid; MDO, membrane-derived 
oligosaccharides. Reprinted with permission from Raetz CRH (1996) Bacterial 
lipopolysaccharides:  A remarkable family of bioactive macroamphiphiles, in Escherichia coli 
and Salmonella:  Cellular and molecular biology (Neidhardt FC ed) pp 1035-1063, ASM Press, 
Washington, D.C.  (B) The LPS macromolecule is divided into two major regions:  the lipid A 
portion and the polysaccharide portion.  The polysaccharide region can be further subdivided.  
Reprinted with permission from, Academic Press Ltd, London UK. 
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Figure 12.  Toxic effects of lipopolysaccharide (LPS).  As gram-negative bacteria begin to 
replicate or die, LPS is released and capable of exerting its pathological effects.  If a gram-
negative bacterial infection is severe enough, it can result in sepsis.  TNF", tumor necrosis factor 
"; IL-1, interleukin-1; IL-6, interleukin-6; PAF, platelet-activating factor; IL-2, interleukin-2.  
Reprinted with permission from Bone RC (1991) The pathogenesis of sepsis, Ann Int Med 
115(6):457-469. 
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 As defined by the American College of Chest Physicians/Society of Critical Care 
Medicine, sepsis is the systemic response to infection (Bone, 1996), and as many as 500,000 new 
cases are reported annually in the United States (Sessler et al., 1996).  Sepsis is a serious medical 
condition with a 40% mortality rate (Marsh and Wewers, 1996).  A few of the clinical 
manifestations of sepsis include fever, hypothermia, tachycardia, tachypnea, oliguria, acidosis, 
and hypotension (Rietschel et al., 1996). Fifty percent of those individuals diagnosed with sepsis 
develop ARDS within the first twenty-four hours after the onset of sepsis.  Acute lung injury is 
recognized clinically as ARDS (Sessler et al., 1996).  The clinical manifestations of ARDS 
include arterial hypoxemia, dyspnea, decreased lung compliance, pulmonary edema, and 
atelectasis (McFeely and Hudson, 1994; Sessler et al., 1996). 
 This dissertation describes an investigation into two separate, but related questions 
pertaining to the role and mechanism(s) of action of EpDRF.  In the first, the effects of epithelial 
ion transport inhibitors on the epithelial bioelectric response to elevated mucosal tonicity were 
examined in order to elucidate which ion channels and/or transporters are involved in the 
epithelial depolarization which precedes EpDRF-induced smooth muscle relaxation.  In the 
second study, the effects of LPS-treatment on EpDRF-induced smooth muscle relaxation and 






















The Relationship Between Epithelial Bioelectric 
Responses and Epithelium-Derived Relaxing Factor-
Induced Airway Smooth Muscle Relaxation in 




 When cells are exposed to a hypertonic environment, they activate RVI mechanisms 
which alter ion transport through perturbations in ion channel and/or transporter activity 
(McManus et al., 1995; Lang et al., 1998).  In addition, when the extraluminal (serosal) and 
intraluminal (mucosal) surfaces of guinea-pig tracheal epithelium are challenged with 
hypertonicity, EpDRF is released (Munakata et al., 1988; Fedan et al., 1999), an event which 
seems to be functionally linked to epithelial ion transport (Dortch-Carnes et al., 1999; Fedan et 
al., 1999).  With a consideration of these statements, the purpose of this study was to characterize 
further the epithelial bioelectric events associated with the synthesis, release, and/or effects of 
EpDRF in guinea-pig isolated trachea. 
 The hypothesis underlying this study was that hypertonicity-induced alterations in 
epithelial ion transport are functionally linked to the synthesis, release, and/or effects of EpDRF.  
The hypothesis was tested by measuring transepithelial short-circuit current (Isc) responses to 
pharmacological agents added to either surface of guinea-pig isolated trachea mounted in Ussing 
chambers.  Dortch-Carnes et al. (1999) have shown that EpDRF-induced smooth muscle 
relaxation is preceded by a depolarization of the transepithelial potential difference while Fedan 
et al. (1999) have shown that EpDRF-induced smooth muscle relaxation is significantly 
attenuated by amiloride (Na+ channel blocker) and DIDS (Cl! channel blocker).  The 
experiments in this study will try to determine which epithelial ion channels and/or transporters 
are involved in the transepithelial depolarization preceding EpDRF-induced airway smooth 
muscle relaxation.  This will be accomplished by examining the effect of various ion channel and 
transporter inhibitors on Isc responses to hypertonic modified Krebs Henseleit (MKH) solution.  
In this study, the MKH solution was made hypertonic by adding either 120 mOsm NaCl or D-




Materials and Methods 
Animals 
 Specific, pathogen-free, male Dunkin-Hartley guinea pigs (Harlan Sprague Dawley, Inc.; 
Indianapolis, IN; 370-714 g) were used during the course of this study.  The guinea pigs were 
housed in separate, actively ventilated, micro-isolator cages (Lab Products, Inc.; Seaford, DE) 
within a single room.  The room within which these animals were housed were part of an 8800 
ft2 modified barrier, animal care facility.  Within this facility, the animals were acclimated to 
their new environment prior to experimentation, given food and water ad libitum, and breathed 
fresh air.  All of the animals in the animal care facility, as well as the facility itself, were under 
the supervision of a full-time veterinarian. 
 Throughout this study, the guinea pigs were sacrificed according to a standard protocol.  
The animals were first anesthetized intraperitoneally (i.p.) with sodium pentobarbital (Veterinary 
Laboratories, Inc.; Lenexa, KS; 65 mg/kg), and once it was determined that the animals were 
unresponsive to any stimuli, they were exsanguinated by severing the abdominal aorta and 
cutting the heart. 
 All of the experimental protocols in this study were approved by the Institutional Animal 
Care and Use Committee (IACUC) while the facilities where the experimental protocols were 
conducted were fully accredited by the Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) International.  These facilities have been accredited by 
AAALAC International since February 18, 1987. 
 
Ussing System 
 A classical Ussing system [World Precision Instruments (WPI); Sarasota, FL] was 
utilized to directly measure Isc in freshly isolated, guinea-pig tracheal segments.  Isc can be 
defined as the current required to offset the spontaneous transepithelial potential difference 
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generated by the tissue.  Under Isc conditions there is no net ion transport; therefore, Isc is a 
measurement of total active ion transport (Soybel, 1994). 
 The Ussing system consisted of two separate, water-jacketed, glass circulation reservoirs 
whose temperature was maintained at 37oC.  The reservoirs were filled with recirculating, MKH 
solution, a physiological salt solution, which was maintained at 37oC and continuously gassed 
with 95% O2-5% CO2.  The reservoirs were connected to opposing hemi-chambers, between 
which a guinea-pig tracheal segment was mounted.  Because of the manner in which the tissue 
was mounted, pharmacological agents could be added selectively to either the mucosal or serosal 
surfaces of the trachea. 
 In order to prepare a guinea-pig tracheal segment for mounting, the animal was sacrificed 
as previously described.  The trachea was exposed in vivo, the entire trachea excised, placed in 
MKH solution gassed with 95% O2-5% CO2, and cleaned of extraneous tissue.  Once cleaned, 
the trachea was slit along its longitudinal axis by cutting through the airway smooth muscle.  The 
trachea was then opened as a flat sheet and cut horizontally so that the proximal end of the 
trachea was mounted in the Ussing chamber.  After mounting, only a 0.125 cm2 surface area of 
the trachea was exposed to the gassed, MKH solution from the glass circulation reservoirs. 
 The fluid which bathed the mucosal and serosal surfaces of the trachea was in contact 
with silver/silver chloride electrode cartridges (WPI; Sarasota, FL) which were filled with 0.9 % 
sodium chloride irrigation, USP (saline; Baxter Healthcare Corporation; Deerfield, IL) in 4 % 
melted bacteriological agar.  A two-channel DVC-1000 voltage/current clamp (WPI; Sarasota, 
FL) was connected to the Ussing chamber via four silver/silver chloride electrodes.  Two 
electrodes, placed distal to the tissue, were connected to the current-passing circuit while two 
electrodes, placed proximal to the tissue, monitored transepithelial potential difference.  Isc was 
measured continuously, and the data recorded on a conventional strip chart recorder (Gould 
Instrument Systems; Valley View, OH).  In addition, the Isc was normalized to surface area.  To 
accomplish this, the Isc was multiplied by the inverse of the surface area of the trachea exposed to 
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the fluid bathing the mucosal and serosal surfaces.  In this instance, the surface area was 
calculated from the formula describing the surface area of a circle: 
surface area of a circle = Br2 
where r is the radius (0.2 cm).  The following sample calculation demonstrates how the Isc was 
eventually expressed in µA/cm2: 
Isc×(1/Br2) 
then, by substitution of arbitrary numerical values 
5.0 µA×1/[B(0.2 cm)2] = 39.8 µA/cm2 
The tissue was equilibrated for 3 hr prior to any experimental manipulations, with the MKH 
solution bathing the mucosal and serosal surfaces of the trachea being changed every 15 min. 
 
Administration of Agents to the Ussing System 
 The Ussing system was used in this study to determine the effect of amiloride (Na+ 
channel blocker), 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; Cl! channel blocker), 
iberiotoxin (Ca2+-activated K+ channel blocker), bumetanide (Na+-K+-2Cl! cotransporter 
inhibitor), and ouabain (Na+-K+-ATPase inhibitor) on tracheal Isc responses to hypertonic 
solution.  During this portion of the study, the effect of a single concentration of hypertonic 
solution on Isc was examined, and in this instance, the MKH solution was made hypertonic by 
adding either120 mOsm of NaCl or D-mannitol to the MKH solution. 
 Following the 3 hr equilibration period, hypertonic NaCl or D-mannitol solution was 
added to the mucosal surface of the trachea in the presence of serosally-added methacholine 
chloride (MCh; 3×10!7 M) in order to mimic conditions in previous EpDRF studies 
(Dortch-Carnes et al., 1999; Fedan et al., 1999).  Once the electrophysiological response to 
hypertonic solution had equilibrated, the preparation was then washed at 15 min intervals for 90 
min with fresh MKH solution. 
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 After the completion of the 90 min wash period, a respective ion channel and/or 
transporter inhibitor was added to either the mucosal or serosal surface of the trachea, depending 
upon the epithelial surface where its molecular target is believed to exist (Figure 6).  Once the 
electrophysiological response of the inhibitor, if any, had equilibrated, hypertonic NaCl or D-
mannitol solution was added again to the mucosal surface of the trachea in the presence of 
serosally-added MCh (3×10!7 M).  There were a few exceptions to this standard protocol.  
Iberiotoxin was added to both the mucosal and serosal surfaces of the trachea for 30 min while 
ouabain was added prior to the addition of MCh to mimic conditions in a previous EpDRF study, 
which was done to prevent Na+ loading of the tracheal smooth muscle (Fedan et al., 1999). 
 
Solutions and Reagents 
 The MKH solution contained (mM):  NaCl (113.0), KCl (4.8), CaCl2 (2.5), KH2PO4 
(1.2), MgSO4 (1.2), NaHCO3 (25.0), and glucose (5.7).  The MKH solution was continuously 
gassed with 95% O2-5% CO2 and maintained at 37oC and a pH of 7.4.  In addition, the 
osmolarity of the MKH solution was 281.2±0.6 mOsm (n = 5; Osmette A Automatic 
Osmometer, Precision Systems, Inc.; Sudbury, MA). 
 All chemical reagents used during the course of this study were purchased from Sigma 
Chemical Co. (St. Louis, MO) and dissolved in distilled water unless otherwise noted.  
Amiloride and ouabain were dissolved in warm, distilled water while bumetanide and NPPB 
were dissolved in dimethyl sulfoxide (DMSO). 
 
Analysis of Results 
 When statistically comparing the Isc in response to hypertonic MKH solution in the 
presence and absence of ion channel or transporter inhibitors, the paired Student’s t test or Mann-
Whitney rank sum test was used, as appropriate. 
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 All of the results were expressed as the mean ± S.E.M. (standard error of the mean) 




Effect of ion transport inhibitors on the basal Isc of isolated trachea 
 The basal Isc of guinea-pig isolated, trachea mounted in Ussing chambers was 47.8±1.6 
µA/cm2 (n = 64).  Treatment of the tissue with mucosally-applied amiloride (3×10!5 M), 
mucosally-applied NPPB (10!4 M), or serosally-applied bumetanide (10!5 M) decreased the 
basal Isc by 35.6±1.4% (n = 12), 83.3±4.9% (n = 8), and 8.9±1.6% (n = 12), respectively.  
Mucosally- and serosally-applied iberiotoxin (10!7 M) had no apparent effect upon the basal Isc.  
In order to mimic previous studies of EpDRF in the isolated, perfused trachea apparatus (Fedan 
et al., 1999), the effect of serosally-applied ouabain (10!5 M) on Isc was measured in the presence 
of serosally-applied MCh (3×10!7 M).  In this instance, ouabain decreased the Isc by 94.3±3.3% 
(n = 8). 
 
Effect of ion transport inhibitors on the bioelectric responses of  
isolated trachea to hypertonic NaCl and D-mannitol solution 
 In order to characterize further the ion channels and/or transporters involved in EpDRF-
induced smooth muscle relaxation (Dortch-Carnes et al., 1999; Fedan et al., 1999), this study 
examined the effect of ion channel and transporter inhibitors on the Isc responses of isolated 
trachea to MKH solution made hypertonic with either added NaCl (120 mOsm) or D-mannitol 
(120 mOsm), both of which have been shown to elicit EpDRF-induced smooth muscle relaxation 
(Munakata et al., 1988; Fedan et al., 1999).  Again, in order to mimic previous studies of EpDRF 
(Dortch-Carnes et al., 
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1999; Fedan et al., 1999), MCh (3×10!7 M) was added serosally prior to the mucosal application 
of hypertonic NaCl or D-mannitol solution.  MCh, itself, increased the Isc which was 
significantly attenuated by bumetanide and NPPB (data not shown). 
 In the presence of serosally-added MCh (3×10!7 M), the bioelectric responses to 
hypertonic NaCl and D-mannitol solution were different (Figure 13).  Mucosally-applied 
hypertonic NaCl solution produced a triphasic response which consisted of a rapid decrease, an 
increase, and finally, a very slow, sustained decrease in Isc.  The triphasic Isc responses were 
difficult to quantify since the first two phases, the rapid decrease and then increase, were variable 
from tissue to tissue; however, the very slow, sustained decrease in Isc was characteristic of all 
tissue responses to hypertonic NaCl solution.  As a consequence, the very slow, sustained 
decrease in Isc was the only phase which was quantified.  The response to hypertonic D-mannitol 
solution was much less complex, consisting of only a very slow, sustained decrease in Isc. 
 Pretreatment with either serosally-applied amiloride (3×10!5 M) or bumetanide (10!5 M) 
significantly inhibited the Isc induced by NaCl and D-mannitol (Figures 14 and 15) while 
mucosally- and serosally-applied iberiotoxin (10!7 M) had no apparent effect on the Isc responses 
to either NaCl or D-mannitol (Figure 16).  In the presence of mucosally-applied NPPB (10!4 M), 
the Isc increased rather than decreased following the addition of NaCl while the Isc induced by 
D-mannitol was almost completely abolished (Figure 17).  Serosally-added ouabain (10!5 M) 
caused a progressive reduction in Isc toward zero.  This prevented assessment of the effect of 
ouabain on responses to NaCl and D-mannitol; however, in the presence of ouabain, the Isc 




Figure 13.  Representative tracing showing the effect of mucosally-applied MKH solution made 
hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol (120 mOsm) on Isc in the 
presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  MCh increased the Isc.  NaCl 
elicited a triphasic response which consisted of (1) a rapid decrease, (2) an increase, and finally, 
(3) a very slow, sustained decrease in Isc.   D-mannitol elicited a very slow, sustained decrease in 
Isc.  As explained in the text, it was the very, slow sustained decrease in Isc which was quantified. 
39 
 
Figure 14.  Effect of mucosally-applied amiloride (3×10!5 M) on the Isc responses of mucosally-
applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol 
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  
Amiloride significantly inhibited the Isc induced by both NaCl and D-mannitol.  n = 6 for NaCl 
and D-mannitol. *p < 0.05 compared to !Amiloride as determined by a paired Student’s t test. 
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Figure 15.  Effect of serosally-applied bumetanide (10!5 M) on the Isc responses of mucosally-
applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol 
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  
Bumetanide significantly inhibited the Isc induced by both NaCl and D-mannitol.  n = 6 for 




Figure 16.  Lack of effect of mucosally- and serosally-applied iberiotoxin (10!7 M) on the Isc 
responses of mucosally-applied MKH solution made hypertonic with added (A) NaCl (120 
mOsm) or (B) D-mannitol (120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in 




Figure 17.  Effect of mucosally-applied NPPB (10!4 M) on the Isc responses of mucosally-
applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol 
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  In the 
presence of NPPB, the Isc increased rather than decreased following the addition of NaCl while 
the Isc induced by D-mannitol was almost completely abolished.  n = 4 for NaCl and D-






Figure 18.  Effect of serosally-applied ouabain (10!5 M) on the Isc responses of mucosally-
applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol 
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  Ouabain 
(10!5 M) caused a progressive reduction in Isc toward zero.  This prevented assessment of the 
effect of ouabain on responses to NaCl and D-mannitol; however, in the presence of ouabain, the 
Isc increased rather than decreased following the application of NaCl and D-mannitol.  n = 4 for 
NaCl and D-mannitol.  *p < 0.05 compared to !Ouabain as determined by a paired Student’s t 
test. 
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 In order to make certain that the responses seen in the presence of the inhibitors were not 
due to the effects of the vehicle, DMSO, the effect of DMSO on the responses was tested.  
DMSO had no effect upon the responses to hypertonic NaCl or D-mannitol solution (Figure 19).  
Finally, to ensure that tissue desensitization did not contribute to the apparent effect of the 
inhibitors, the effect of hypertonic NaCl and D-mannitol solution on Isc responses was measured 
twice in the same preparation (Figure 20).  The second response was measured 90 min after the 
first, with washes every 15 min. There was no difference between the first and second response 
to D-mannitol, but there was a significant decrease in the second NaCl response when compared 






Figure 19.  Lack of effect of mucosally- and serosally-applied DMSO on the Isc responses of 
mucosally-applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-
mannitol (120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  
The final concentration of DMSO bathing the mucosal surface of the trachea was 0.08% while 






Figure 20.  Comparison of the first and second Isc responses to mucosally-applied MKH solution 
made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol (120 mOsm) in the 
presence of serosally-applied MCh (3×10!7 M) in isolated trachea.  The second Isc induced by 
NaCl was slightly, but significantly less than the first while there was no difference between the 
first and second Isc induced by D-mannitol.  n = 4 for NaCl and D-mannitol.  *p < 0.05 
compared to the first response as determined by a paired Student’s t test. 
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Discussion 
 The results of this study suggest that apical Na+ channels and basolateral Na+-K+-2Cl! 
cotransporters are intimately involved in the airway epithelial bioelectric response to elevated 
mucosal tonicity while the role of apical Cl! channels and basolateral Na+-K+-ATPases is 
unclear.  Since apical Na+ channels are involved in both the epithelial bioelectric response to 
elevated mucosal tonicity and hypertonicity-induced smooth muscle relaxation via EpDRF, this 
further strengthens the hypothesis that the synthesis, release, and/or effects of EpDRF are 
functionally linked to the electrical activity of the epithelium (Raeburn and Fedan, 1989; Dortch-
Carnes et al., 1999; Fedan et al., 1999). 
 Although the major objective of this study was to elucidate which epithelial ion channels 
and/or transporters were involved in the depolarization of the transepithelial potential difference 
(Vms) preceding EpDRF-induced smooth muscle relaxation, this study has made other 
observations regarding the basic electrophysiological properties of guinea-pig tracheal 
epithelium.  The basal Isc value obtained in this study was not consistent with two previous 
studies measuring Isc in guinea-pig tracheal epithelium (Croxton, 1993; Robison and Kim, 1994).  
The reasons for these discrepancies are not clear; however, both of these studies used animals in 
a lower weight range which may be important if epithelial ion transport is size- and/or age-
dependent.  More importantly, the difference may lie in the arrangement of the tissue. Croxton 
(1993) measured Isc in intact trachea while Robison and Kim (1994) measured Isc in cultured, 
tracheobronchial epithelial cells.  This is most significant when comparing our results with those 
from cultured cells since submucosal tissues have been shown to modulate the bioelectric 
properties of the airway epithelium (Freed and Croxton, 1993).  The lack of an airway wall and 
its modulatory effects in cultured cells may explain these differences.  Our basal Isc value 
(47.8±1.6 µA/cm2), however, was consistent with a separate study (37.3±2.9 µA/cm2) which also 
measured Isc in guinea-pig tracheal segments mounted in Ussing chambers 
(Stutts and Bromberg, 1987). 
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 The effects of several ion transport inhibitors on the basal Isc produced results which 
contradicted the current, presumed model of ion transport in guinea-pig tracheal epithelium.  The 
current model proposes that under resting Isc conditions Na+ absorption is the major ion transport 
process which accounts for the majority of the Isc (Boucher et al., 1982).  In this study, amiloride 
decreased the basal Isc by 35.6±1.4% which is consistent with a Na+ absorptive epithelium; 
however, other studies have shown the effect of amiloride on baseline Isc to be much greater.  
Croxton (1993) reported that amiloride (3×10!5 M) decreased the baseline Isc by approximately 
50% while Robison and Kim (1994) reported that amiloride (10!5 M) decreased the baseline Isc 
by approximately 75%.  Again, these discrepancies may be explained by the same reasons given 
for the differences seen in the basal Isc among the different preparations. 
 Our results became more contradictory when the effect of NPPB, a Cl! channel blocker, 
on baseline Isc was examined.  NPPB abolished 83.3±4.9% of the basal Isc.  Despite the fact that 
the current model of ion transport in guinea-pig tracheal epithelium proposes that there is no net 
Cl! secretion (Boucher et al., 1982), our results with NPPB suggest that Cl! secretion may be the 
predominant ion transport process of this epithelium.  Robison and Kim (1994) used another Cl! 
channel blocker, N-phenylanthranilic acid, which decreased the basal Isc of cultured, 
tracheobronchial epithelial cells by approximately 20 %.  On the surface, the effect of NPPB 
suggests that the majority of the Isc is due to Cl! secretion; however, NPPB is a nonselective Cl! 
channel blocker.  In fact, NPPB has been shown to inhibit the Ca2+ release-activated Ca2+ 
channel as well as the activity of the Na+-K+-ATPase which may account for its large inhibition 
of baseline Isc (Ito et al., 2000; Li et al., 2000). 
 With respect to the effect of hypertonic solution on Isc responses in the presence of 
serosally-added MCh (3×10!7 M), the results of this study demonstrate that these responses are 
dependent upon the osmolyte used to elevate mucosal tonicity.  The triphasic change in Isc 
following the addition of hypertonic NaCl solution is very intriguing; however, the 
electrophysiological basis of the first two phases, the rapid decrease followed by an increase, 
could not be elucidated because these particular responses were inconsistent between and within 
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animals.  In response to MKH solution made hypertonic with either NaCl or D-mannitol, there 
was always a slow, sustained decrease in Isc, indicating that this electrophysiological response is 
the characteristic bioelectric response of the airway epithelium to elevated mucosal tonicity. 
 Since MKH solution made hypertonic with either added NaCl or D-mannitol elicited a 
slow, sustained decrease in Isc, the effect of ion transport inhibitors on this particular response 
was evaluated. This decrease in Isc following an elevation in mucosal tonicity may be explained 
by the same mechanisms believed to account for hyperosmotic stress of the airways during dry 
air hyperpnea (Figure 10; Anderson and Daviskas, 1999).  Because elevated mucosal tonicity 
would decrease the osmotic pressure of the ASL, water would exit the cell; thus, intracellular 
Na+ and Cl! concentrations would increase.  Consequently, this would decrease Na+ absorption 
and increase Cl! secretion.  A decrease in Na+ absorption and an increase in Cl! secretion would 
decrease and increase the Isc respectively, and the net effect on Isc would be dependent upon 
which ion transport process dominates.  In addition, the effect on Isc elicited by elevated mucosal 
tonicity is also dependent upon the paracellular pathway conductance.  A previous study reported 
that the decrease in Isc following elevated mucosal tonicity was due to a decrease in Na+ 
absorption.  In fact, this same study also reported that Cl! secretion was not induced by elevated 
mucosal tonicity (Willumsen et al., 1994).  This explanation describing the decrease in Isc fits 
with the effects of D-mannitol since it is membrane-impermeable; however, the effects of NaCl 
are more complicated because it is membrane-semipermeable.  In order to fully elucidate the 
particular ion fluxes which are altered following exposure of the tracheal epithelium to elevated 
mucosal tonicity, isotope flux studies are necessary. 
The significant attenuation of the hypertonicity-induced Isc by amiloride, regardless 
of the osmolyte used to elevated tonicity, suggests that apical Na+ channels are involved in the 
epithelial bioelectric response to elevated mucosal tonicity.  In the presence of amiloride, the Isc 
response to elevated mucosal tonicity is most likely reduced for two reasons.  First, Na+ is unable 
to leave the cell across the apical membrane in the presence of amiloride.  Secondly, amiloride 
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stimulates Cl! secretion (Boucher et al., 1982), which would offset any decrease in Isc by 
hypertonic solution. 
 The significant, inhibitory effect of bumetanide on hypertonicity-induced Isc, regardless 
of the osmolyte used to elevate tonicity, suggests that basolateral Na+-K+-2Cl! cotransporters 
along with apical Na+ channels are involved in the epithelial bioelectric response to elevated 
mucosal tonicity.  The reason bumetanide attenuates the Isc elicited by elevated mucosal 
tonicity is dependent upon the existence and activation of another basolateral Cl!-coupled 
transporter when the Na+-K+-2Cl! cotransporter is inhibited.  Two candidates include the Cl!-
HCO3! exchanger and the Na+-coupled Cl! transporter.  In fact, the Na+-coupled Cl! transporter 
is postulated to exist in the basolateral membranes of Cl! secretory epithelia 
(Frizzell et al., 1979).  How would the action of the Na+-coupled Cl! transporter, if it exists in 
guinea-pig tracheal epithelium, offset the decrease in Isc elicited by elevated mucosal tonicity?  
According to the model of hyperosmotic stress of the airways during dry air hyperpnea, not only 
do the intracellular concentrations of Na+ and Cl! increase, but also the extracellular 
concentrations of these ions in the submucosa (Figure 10) (Anderson and Daviskas, 1999) which 
would tend to drive these ions into the overlying epithelial cell by means of the Na+-coupled Cl! 
transporter if the Na+-K+-2Cl! cotransporter is inhibited by bumetanide.  Na+ and Cl! would 
begin to accumulate in the cell, and in order to obtain electrochemical equilibrium, they must be 
extruded across either the apical or basolateral membranes.  According to the model proposed by 
Frizzell et al. (1979), Na+ is extruded from the cell by the action of the basolateral Na+-K+-
ATPase while Cl! is driven from the cell across the apical membrane.  In the presence of 
hypertonicity, the intracellular Cl! concentration is increased so any further increase would 
accentuate its secretion across the apical membrane.  This stimulation of Cl! secretion would 
offset the decrease in Isc elicited by hypertonic solution.  This scenario holds true only if another 
Cl!-coupled transporter is activated following inhibition of the Na+-K+-2Cl! cotransporter. 
 Unlike amiloride and bumetanide, the effects of NPPB on hypertonicity-induced Isc 
was osmolyte dependent.  In the presence of NPPB, hypertonic NaCl solution increased rather 
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than decreased the Isc.  Under basal conditions, NPPB will hyperpolarize the apical membrane; 
therefore, it will consequently stimulate Na+ absorption and increase Isc.  The addition of 
hypertonic NaCl solution will increase the inward Na+ gradient, which, in all likelihood, will 
potentiate Na+ influx when Cl! is elevated inside the cell by NPPB.  This enormous inward Na+ 
flux will increase the Isc response in such a way that it overwhelms any Isc decrease evoked by 
elevated mucosal tonicity. NPPB almost completely abolished the Isc induced by hypertonic D-
mannitol.  Since NPPB did not have the same effect on Isc elicited by hypertonic D-mannitol 
and NaCl, this suggests that role of apical Cl! channels in the epithelial bioelectric response to 
elevated mucosal tonicity is osmolyte dependent, and at this moment, unclear.  The application 
of hypertonic D-mannitol to the mucosal surface will drive Na+ across the apical membrane, 
decreasing Isc; however, this decrease is almost completely abolished, meaning it must be 
opposed by an increase in Isc by some other ion, namely Cl!.  The only manner in which this can 
occur is by movement of Cl! out of the cell across the basolateral membrane or through apical 
Cl! channels which are insensitive to NPPB.  Exit across the basolateral membrane could occur 
through either the Na+-K+-2Cl! cotransporter or the Cl!-HCO3! exchanger and/or possibly the 
Na+-coupled Cl! transporter if they exist in guinea-pig tracheal epithelium. 
 The lack of effect of iberiotoxin on Isc induced by hypertonic solution suggests that 
Ca2+-activated K+ channels have no apparent role in the epithelial bioelectric response to 
elevated mucosal tonicity; however, this does not rule out the possibility of other K+ channels 
being involved.  Although the effects of ouabain, a Na+-K+-ATPase inhibitor, on Isc changes 
induced by hypertonic solution were examined in this study, the results were inconclusive since 
ouabain completely abolished the Isc.  A further characterization of the possible involvement of 
the Na+-K+-ATPase in the epithelial bioelectric response to elevated mucosal tonicity is 
impossible since its pharmacological inhibitor, ouabain, completely abolishes the baseline Isc. 
 When comparing the first and second epithelial bioelectric responses to hypertonic NaCl 
or D-mannitol solution in the same tissue, the second response to NaCl, not D-mannitol, was 
significantly less than the first; however, this effect was not as great as the effect of the tested 
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inhibitors on reducing Isc. This indicates that the tissue desensitizes in response to hypertonic 
NaCl solution and that some of the reduction in Isc seen with the inhibitors is partially due to 
desensitization. 
 The overall goal of this study was to demonstrate that those ion channels involved in 
hypertonicity-induced smooth muscle relaxation via EpDRF were also involved in the epithelial 
bioelectric response to elevated tonicity, and if this was found to be the case, this would further 
support the hypothesis that the synthesis, release, and/or effects of EpDRF are functionally 
linked to epithelial electrical activity.  Fedan et al. (1999) reported that apical Na+ and 
Cl!channels were involved in EpDRF-induced smooth muscle relaxation; however, this study 
has shown that apical Na+ channels and basolateral Na+-K+-2Cl! cotransporters are involved in 
the epithelial bioelectric response to elevated mucosal tonicity while the role of apical 
Cl!channels and basolateral Na+-K+-ATPases is unclear. 
 Because amiloride significantly attenuated hypertonicity-induced smooth muscle 
relaxation via EpDRF and the epithelial bioelectric response to elevated mucosal tonicity, this 
provides further evidence that apical Na+ channels are intimately involved in the synthesis, 
release, and/or effects of EpDRF.  The role of these channels in mediating EpDRF-induced 
relaxation responses is unclear. Because the mechanisms by which eukaryotic cells sense 
increases or decreases in extracellular tonicity are poorly understood (Cohen, 1997), it is possible 
that these Na+ channels are in fact osmotic sensors which initiate EpDRF synthesis and/or 
signaling by relaying extracellular changes in tonicity to the intracellular environment.  If the 
normal activity of these channels are interfered with by amiloride, it may alter their ability to 
sense changes in tonicity and/or communicate these changes to the intracellular environment.  It 
is very unlikely that amiloride-sensitive Na+ channels are the only, possible osmotic sensors of 
the airway epithelial cells given the fact that elevations in serosal tonicity also lead to the 
synthesis, release, and/or effects of EpDRF (Fedan et al., 1999).  It is possible that each epithelial 
surface may have its only osmotic sensor.  Because the Na+-K+-2Cl! cotransporter is also 
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involved in the epithelial bioelectric response to elevated mucosal tonicity, the possibility exists 
that this transporter is the osmotic sensor of the basolateral surface. 
 Fedan et al. (1999) reported that bumetanide produced a modest inhibition (p < 0.07) of 
EpDRF-induced smooth muscle relaxation at added NaCl concentrations equal or greater than 
150 mOsm; however, this study has shown that bumetanide attenuated Isc changes evoked by 
only 120 mOsm of added NaCl or D-mannitol.  The inconsistency between the effects of 
bumetanide on EpDRF-induced smooth muscle relaxation and hypertonicity-induced Isc 
suggests that the Na+-K+-2Cl! cotransporter is involved in the epithelial bioelectric response to 
elevated hypertonicity but not appreciably involved in EpDRF-induced smooth muscle 
relaxation.  From this study, the relationship between the mechanical and bioelectric effects of 
Cl! channel blockers on hypertonicity-induced smooth muscle relaxation and epithelial 
bioelectric responses, respectively, cannot be determined. Fedan et al. (1999) used DIDS, a Cl! 
channel blocker and Cl!-HCO3! exchanger inhibitor (Lamb et al., 2000), rather than NPPB, a 
nonselective Cl! channel blocker, to come to the conclusion that apical Cl! channels are involved 
in mediating EpDRF-induced smooth muscle relaxation.  The effect seen with DIDS may have 
nothing to do with its effect upon apical Cl! channels but everything to do with its effect upon 
the Cl!-HCO3! exchanger.  In order for further clarification of the role of Cl! channels and/or 
transporters, the effect DIDS on Isc and NPPB on EpDRF-induced smooth muscle relaxation, 
respectively, will have to be examined.  Finally, there is a discrepancy between the lack of effect 
of iberiotoxin on the epithelial bioelectric response to elevated mucosal tonicity and its inhibitory 
effect on the synthesis and/or release of EpDRF.  Tamaoki et al. (1997) used iberiotoxin to 
examine the basal synthesis and/or release of EpDRF, that is, they did not evoke the effects of 
EpDRF by elevating mucosal or serosal tonicity.  For further clarification of the possible 
involvement of Ca2+-activated K+ channels in this response, the effect of iberiotoxin on EpDRF-
induced smooth muscle relaxation should be examined by stimulating the effects of EpDRF with 
hypertonic solution.  If iberiotoxin fails to have any effect on EpDRF-induced smooth muscle 
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relaxation elicited with hypertonic solution, this could suggest that the basal and stimulated 
release of EpDRF are controlled by different mechanisms. 
 The mechanisms by which hypertonicity-induced changes in epithelial bioelectric activity 
lead to the synthesis, release, and/or effects of EpDRF are unclear; however, the phenomenon of 
electrical signals releasing autacoids is not unheard of in physiological systems.  For example, 
the release of EpDRF from the airway epithelium, due to altered epithelial electrical activity, 
may be analogous to the release of ACh from nerve terminals following the propagation of an 
action potential along the length of a neuron.  It is possible that EpDRF, like ACh, is 
prepackaged in vesicles and released from its cell of origin following a change in the potential 
difference across the cell membrane. 
 There were two major points brought about following the conclusion of this study.  First, 
the basic physiological ion transport properties of guinea-pig tracheal epithelium need to be 
further investigated since this study has shown, contrary to the accepted model, that guinea-pig 
tracheal epithelium may be a Cl!secretory epithelium rather than a Na+ absorbing epithelium.  
Secondly, these results demonstrate that the epithelial bioelectric response to elevated mucosal 
tonicity is mediated by the actions of amiloride-sensitive Na+ channels and the bumetanide-
sensitive Na+-K+-2Cl! cotransporter while the role of apical Cl! channels and basolateral Na+-
K+-ATPases is unclear. Because amiloride attenuated hypertonicity-induced smooth muscle 
relaxation via EpDRF (Fedan et al., 1999) and the epithelial bioelectric response to elevated 
mucosal tonicity, apical Na+ channels appear to be heavily involved in the synthesis, release, 














Lipopolysaccharide-Induced Alterations in Epithelial 
Electrophysiology in Relation to Epithelium-Derived 




 Previous work has suggested that the synthesis, release, and/or effects of EpDRF are 
functionally linked to the electrical activity of epithelial cells (Raeburn and Fedan, 1989; Dortch-
Carnes, et al., 1999; Fedan et al., 1999); therefore, this study sought to determine what effects 
alterations in epithelial ion transport had upon EpDRF-induced airway smooth muscle relaxation.  
The hypothesis of this study was that alterations in epithelial ion transport were associated with 
changes in EpDRF-induced smooth muscle relaxation since the two appear to be functionally 
linked; therefore, any change in the bioelectric properties of the airway epithelium should 
subsequently effect the synthesis, release, and/or effects of EpDRF.  Because LPS-treatment (4 
mg/kg, i.p.; 18 hr post-treatment) has been shown to alter the basal bioelectric properties of 
guinea-pig tracheal epithelium (Johnston and Fedan, 1999), this model system was utilized to 
examine what effect altered epithelial ion transport had upon EpDRF-induced smooth muscle 
relaxation. 
 The hypothesis was tested through a variety of different experiments.  First, tracheal 
smooth muscle mechanical responses (contraction and relaxation) and epithelial bioelectric 
responses (Vms) were measured in isolated, perfused trachea from saline (control)- and LPS-
treated guinea pigs.  If it is found that LPS-treatment alters EpDRF-induced smooth muscle 
relaxation, it will then be hypothesized that airway reactivity to contractile agonists in vitro and 
in vivo will also be altered. 
 
Materials and Methods 
Animals 
 Specific, pathogen-free, male Dunkin-Hartley guinea pigs (Harlan Sprague Dawley, Inc.; 
Indianapolis, IN; 405-700 g) were used during the course of this study.  The guinea pigs were 
housed in separate, actively ventilated, micro-isolator cages (Lab Products, Inc.; Seaford, DE) 
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within a single room.  The room within which these animals were housed were part of an 8800 
ft2 modified barrier, animal care facility.  Within this facility, the animals were acclimated to 
their new environment prior to experimentation, given food and water ad libitum, and breathed 
fresh air.  All of the animals in the animal care facility, as well as the facility itself, were under 
the supervision of a full-time veterinarian. 
 Throughout this study, the guinea pigs were sacrificed according to a standard protocol.  
The animals were first anesthetized intraperitoneally (i.p.) with sodium pentobarbital (Veterinary 
Laboratories, Inc.; Lenexa, KS; 65 mg/kg), and once it was determined that the animals were 
unresponsive to any stimuli, they were exsanguinated by severing the abdominal aorta and 
cutting the heart. 
 All of the experimental protocols in this study were approved by the Institutional Animal 
Care and Use Committee (IACUC) while the facilities where the experimental protocols were 
conducted were fully accredited by the Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) International.  These facilities have been accredited by 
AAALAC International since February 18, 1987. 
 
In Vivo Saline- and Lipopolysaccharide-Treatments 
 Guinea pigs were injected i.p. with 4 mg/kg lipopolysaccharide (LPS) from Salmonella 
typhimurium or a volume equivalent of 0.9 % sodium chloride irrigation, USP (saline, control; 
Baxter Healthcare Corporation; Deerfield, IL).  Eighteen hr after treatment, in vitro or in vivo 
experiments were conducted. 
 
Isolated, Perfused Trachea Apparatus 
 The isolated, perfused trachea apparatus (Figure 21) is a unique in vitro preparation 
which is used to measure tracheal smooth muscle contractile and relaxant responses in response 
to various pharmacological agents (Munakata et al., 1988; Fedan and Frazer, 1992). 
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 This preparation consisted of two separate, water-jacketed organ baths whose 
temperature was maintained at 37oC.  The 30 ml extraluminal (EL) or serosal bath and the 30 ml 
intraluminal (IL) or mucosal bath were filled with MKH solution that was continuously gassed 
with 95% O2-5% CO2.  In order to remove the trachea from the guinea pig, the animal was 
sacrificed as previously described.  The trachea was exposed in vivo, a 4.2 cm segment excised, 
placed in MKH solution gassed with 95% O2-5% CO2, and cleaned by removing extraneous 
tissue.  The trachea was then mounted on a stainless steel perfusion holder, stretched to its in situ 
length, and placed into the EL bath containing gassed MKH solution.  After attaching the 
necessary tubing, the trachea was perfused, at a constant rate of 34 ml/min, with gassed, 
recirculating MKH solution (37oC) from the separate IL bath.  Since the tracheal smooth muscle 
and epithelium were in direct contact with the gassed MKH solution in the EL and IL baths, 
respectively, pharmacological agents added to the EL bath have direct access to the smooth 
muscle while those agents added to the IL bath must first diffuse through the epithelium before 
reaching the smooth muscle.  This preparation, therefore, allowed one to study the degree to 
which the epithelium can modulate airway reactivity. 
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Figure 21.  Isolated, perfused trachea apparatus.  A 4.2 cm length of guinea-pig trachea, shownin 
blue, is attached to a perfusion holder and placed in the extraluminal (EL) or serosal bath 
containing modified Krebs-Henseleit (MKH) solution maintained at 37oC.  Once all of the 
necessary tubing is attached, the intraluminal (IL) or mucosal surface of the trachea is perfused at 
a constant rate with recirculating MKH solution also maintained at 37oC.  The red arrows 
indicate the direction of fluid flow through the preparation.  As explained in the text, this 
preparation can measure contractile and relaxant responses of the tracheal smooth muscle 
(illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.). 
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 Contractile and relaxant responses of the tracheal smooth muscle were measured as 
changes in the inlet minus outlet pressure difference ( P; cm H2O) between the side holes of 
two indwelling catheters which became inserted into the lumen upon mounting the trachea to the 
holder (Figure 22). The proximal and distal ends of the trachea were attached with suture 
(Deknatel, Inc.; Fall River, MA) around the inlet and outlet catheters, respectively.  The inlet and 
outlet catheters were connected by pressure lines to the positive and negative sides, respectively, 
of a differential pressure transducer (Validyne Engineering Corp.; Northridge, CA).  Because the 
rate of fluid movement through the trachea was kept constant (34 ml/min), the P responses 
were representative of changes in tracheal cross-sectional area associated with contraction and 
relaxation; therefore, an increase or decrease in P was associated with smooth muscle 
contraction and relaxation, respectively (Munakata et al., 1989).  These responses were recorded 
on a conventional strip chart recorder (Gould Instrument Systems; Valley View, OH).  In all 
instances, the transmural pressure was zeroed, and the preparations were equilibrated for 3 hr 
before any experimental manipulations were initiated.  During the equilibration period, however, 




Figure 22.  Differential pressure measurement in the isolated, perfused trachea apparatus.  
Contractile and relaxant responses of the tracheal smooth muscle are measured as changes in the 
inlet minus outlet pressure difference ( P) between the side holes of the indwelling perfusion 
holder catheters.  The trachea is shown in blue, and the red arrows indicate the direction of fluid 
flow through the trachea (illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.). 
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Modified Isolated, Perfused Trachea Apparatus 
 Recent modifications to the isolated, perfused trachea apparatus now permit 
transepithelial potential difference (Vms; Dortch-Carnes et al., 1999) to be measured 
simultaneously with smooth muscle contractile and relaxant responses at the proximal and distal 
ends of the trachea.  The experimental setup of this preparation was unchanged from before 
(Figure 21); however, modifications of the perfusion holder were made to measure epithelial 
bioelectric responses.  Because epithelial bioelectric responses were measured with this 
preparation, a plastic perfusion holder, rather than a stainless steel one, was used.  For the most 
part, the plastic perfusion holder did not affect the manner in which smooth muscle mechanical 
responses ( P) were measured; however, the flow rate in this preparation was kept constant at 
22 ml/min instead of the 34 ml/min used with the stainless steel holder, which permitted 
transmural pressure to be zeroed in the face of a greater fluid resistance of the plastic holder.  A 
schematic illustration of the modified perfusion holder is shown in Figure 23. 
 During the course of this study, Vms measurements were made at the proximal end of the 
trachea, and the epithelium surrounding the opening of the inlet catheter was the point source for 
the measurement of the Vms.  Two silver/silver chloride calomel half cells, one designated as IL 
or mucosal (Vm) and the other as EL or serosal (Vs), were used to measure the Vms.  Each 
calomel half cell was in contact with the fluid bathing either the EL or IL surfaces of the trachea 
by means of Ussing voltage electrode cartridges [World Precision Instruments (WPI); Sarasota, 
FL] filled with 3 M KCl in 4 % melted bacteriological agar.  The Vms was equal to the sum of 
Vm, Vs, and an offset potential.  Before the trachea was mounted on the perfusion holder, any 
potential difference between the electrodes, not exceeding ±2 mV, was dialed to zero 







Figure 23.  Vms measurement in the modified isolated, perfused trachea apparatus.  The Vms can 
be measured at either the proximal or distal end of the trachea through the side hole of the 
indwelling perfusion holder catheter; however, this study measured the Vms only at the proximal 
end of the trachea.  Again, the trachea is shown in blue and the red arrows indicate the direction 
of fluid flow through the trachea.  The negative sign (!) refers to the fact that the airway 
epithelium generates a lumen-negative potential with respect to the positive (+), basolateral 
surface (illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.). 
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 A two-channel DVC-1000 voltage/current clamp (WPI; Sarasota, FL) was used in the 
measurement of tracheal Vms responses.  The Vms was recorded continuously under open-circuit 
conditions on a conventional strip chart recorder (Gould Instrument Systems; Valley View, OH). 
 
In Vitro Elevated Tonicity Concentration-Response Curves 
 EpDRF release was stimulated by increasing the tonicity of the MKH solution perfusing 
the IL surface of the trachea with either NaCl, KCl, D-mannitol, or urea.  After obtaining a stable 
contraction with extraluminally-added MCh (3×10!7 M; ~EC50 for contraction), concentration-
response curves for relaxation were generated by adding the osmolytes in stepwise-increasing, 
cumulative concentrations to the IL bath.  Equiosmolar, rather than equimolar, concentrations of 
the osmolytes were added to the IL bath.  The relaxation responses were normalized as a 
percentage of the MCh-induced contraction. 
 In addition, concentration-response curves for Vms were generated by adding NaCl in 
stepwise-increasing, cumulative concentrations to the EL and/or IL baths in the presence and 
absence of MCh.  The EL and IL curves were obtained from each trachea, the IL curve first, 
followed 90 min later by the EL curve. 
 
In Vitro Effects of Agents on EpDRF-Induced Smooth Muscle Relaxation 
 During the course of this study, inhibitors of enzymes important to the synthesis of nitric 
oxide and prostanoids were utilized to determine whether or not they affected EpDRF-induced 
smooth muscle relaxation.  Each inhibitor was added to the EL and IL baths 30 min prior to 
inducing muscle tone with extraluminally-added MCh (3×10!7 M; ~EC50).  When relaxation 
concentration-response curves were generated, the effect of an inhibitor upon responses was 
compared to the responses in control preparations where the inhibitor was absent. 
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In Vitro Effects of Agents on the Basal Vms 
 In some experiments, the effects of indomethacin, NT-nitro-L-arginine methyl ester (L-
NAME), atropine, sodium nitroprusside, and amiloride on the basal Vms were determined.  
Indomethacin, L-NAME, atropine, and sodium nitroprusside were added to the EL and IL baths 
simultaneously while amiloride was only added to the IL bath. 
 The effect of LPS on the basal Vms was determined in tracheas from naive animals by 
adding 10 µg/ml of LPS to the EL and IL baths simultaneously.  An untreated, control 
preparation was run in parallel as a time control. 
 
In Vitro MCh Concentration-Response Curves 
 MCh concentration-response curves were generated by adding MCh in stepwise-
increasing, cumulative concentrations to the EL and IL baths.  EL and IL MCh concentration-
response curves were obtained from each trachea, the EL curve first, followed 90min later by the 
IL curve, with washes every 15 min.  The contractile responses to MCh were normalized as a 
percentage of the maximum MCh-induced contraction. 
 
Tracheal Epithelium Removal 
 In isolated, perfused trachea experiments requiring removal of the tracheal epithelium, a 
trimmed, 6-cm segment of pipe cleaner (Fisher Scientific; Pittsburgh, PA) was slowly and 
carefully inserted into the tracheal lumen and then withdrawn while rotating slowly 
(Fedan and Frazer, 1992). 
 
Pulmonary Function Measurements 
 A plethysmograph is used to measure lung volumes and pulmonary function parameters 
in vivo. In this study, a two-chambered, whole-body plethysmograph (Figure 24) was used 
(Buxco Electronics, Inc.; Sharon, CT). 
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 A conscious guinea pig was placed in the plethysmograph so that its head and thorax 
were in the head and body chamber, respectively.  In addition, two latex collars were placed 
around the animal’s neck in order to restrain it.  Besides restraining the animal, the collars form 
an airtight seal between the two chambers.  The guinea pig breathed fresh air through a port in 
the head chamber, and administered agents entered the head chamber through a separate, aerosol 
port.  The head and thoracic chambers were equipped with identical wire screen 
pneumotachographs and SEN1 differential pressure transducers.  The differential pressure 
transducers measured pressure changes within each chamber and were connected to an LS-20 



















Figure 24.  Two-chambered, whole-body plethysmograph.  The two-chambered, whole-body 
plethysmograph is used along with its associated equipment to measure in vivo pulmonary 
function parameters and reactivity to inhaled, MCh aerosol.  Reprinted from J Pharmacol 
Toxicol Methods, Chong BTY, Agrawal DK, Romero FA and Townley RG, Measurement of 
bronchoconstriction using whole-body plethysmograph:  Comparison of freely moving versus 
restrained guinea pigs, pp 163-168, 1998, with permission from Elsevier Science. 
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 The plethysmograph was capable of measuring ten pulmonary function parameters from 
a single breath, but this study was only concerned with two:  breathing frequency (BF) and 
specific airway resistance (SRaw).  The first parameter of interest, BF, was expressed as the 
number of breaths per minute (BPM).  The computer analyzes each breath with regard to four 
exclusion criteria:  (1) the minimum inspiratory time, (2) the maximum inspiratory time, (3) the 
peak expiratory flow, and (4) the percent maximum deviation between the inspiratory and 
expiratory volume.  A breath must fall in the normal range of all four criteria in order to be 
recorded (Lomask, 1996). 
 SRaw is the product of airway resistance and thoracic gas volume and is expressed in 
cm H2O•s.  SRaw is an indicator of airway resistance, and in mathematical terms, it can be 
described by the following equation: 
SRaw = tan2(Patm - 47)(1.36)(Ti/B) 
 
Figure 25 illustrates the derivation of theta (2) which can also be expressed mathematically by 
the following equation: 
2 = B( T)/Ti 
T is the delay time between the zero crossings of nasal and thoracic flows at the end of 
inspiration.  T is computed in seconds and used to calculate 2, which is the phase shift 
between the nasal and thoracic flows.  The additional components of the SRaw equation are as 
follows:  (1) 1.36 is the conversion factor from mm Hg to cm H2O, (2) Patm is the barometric 
pressure in mm Hg, and (3) Ti is the inspiratory time (Lomask, 1996). 
 Both SRaw and BF data were logged at 6 sec intervals with the mean of ten consecutive 
averages taken as the measurement at each time point. 
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In Vivo MCh Dose-Response Curves 
 The guinea pig was placed in the two-chambered, whole-body plethysmograph 24 hr 
prior to generating an in vivo MCh concentration-response curve, and the animal was acclimated 
to the chamber for 2 hr in air.  This reduced the stress that the animal experienced when placed in 
the plethysmograph a second time.  On the second day, the animal was again placed in the 
plethysmograph and acclimated in air for 20 min.  During this 20 min period, SRaw and BF were 
continuously recorded to get basal SRaw and BF values.  Next, a saline aerosol vehicle was 
delivered to the head chamber for 3 min, and at the end of this period, SRaw and BF data were 
taken at 6 sec intervals for 3 min as the animl breathed air.  After a 30 min resting period, the 
lowest concentration of MCh aerosol was delivered to the head chamber for 3 min.  Once the 
aerosol delivery was stopped, SRaw and BF were again measured for 3 min as the animal 
breathed air.  After 30 min, SRaw and BF returned to their basal values, and the next higher 
concentration of MCh was delivered to the chamber and the procedure was repeated with 
increasing MCh concentrations.  Unlike in vitro experiments, a full in vivo dose-response curve 
was impossible to generate because the animals cannot tolerate dyspnea accompanying a 
maximum response; therefore, ED50's and maximum responses could not be determined.  MCh 
concentrations ranging between 0.0316 and 3.16 mg/ml were delivered.  
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Figure 25.  Definition of theta.  A schematic illustration of guinea-pig head (nasal) and body 
(thoracic) airflow during inspiration and expiration as recorded by the data collection system 
associated with the two-chambered, whole-body plethysmograph.  Since thoracic airflow 
precedes nasal airflow at the zero crossing following inspiration, T (delay time) can be 
calculated, which is subsequently used to calculate theta (2).  Reprinted from Lomask K (1996) 
BioSystem XA User's Manual, Version 0.9.3, Buxco Electronics, Inc., Sharon, CT with 
permission from Buxco Electronics, Inc. 
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The MCh PC200, the provocative MCh concentration producing a two-fold increase in basal 
SRaw, was calculated by linear interpolation of graphed data.  All aerosols were generated using 
an Ultra Neb 99 DeVilbiss nebulizer (DeVilbiss Co.; Somerset, PA) containing 5 ml of solution. 
 When examining the effects of saline- and LPS-treatments on airway reactivity to inhaled 
MCh aerosol, a standard protocol was followed.  Naive animals were acclimated on day 1 and 
the same animals exposed to MCh aerosols on day 2.  These animals were then treated with 
saline or LPS, and 18 hr post-treatment, airway reactivity to inhaled MCh was determined.  In all 
instances, each animal served as its own control since reactivity to MCh was determined before 
and after saline- and LPS-treatments. 
 
In Vivo Administration of L-NAME 
 To test the possibility that inhaled L-NAME aerosol may affect airway reactivity to 
inhaled MCh in saline- and LPS-treated animals, guinea pigs were exposed to L-NAME aerosol 
(1.2 mM) for 5 min prior to the delivery of each MCh concentration.  Two MCh concentration-
response curves were generated in both saline- and LPS-treated animals, the first in the absence 
and the second after treatment with L-NAME. 
 
Histological Examination of Guinea-Pig Airways 
 Following anesthesia and exsanguination, trachea and lungs from saline- and LPS-treated 
animals were inflated with 15-20 ml of 10% buffered formalin phosphate (Fisher Scientific; 
Pittsburgh, PA) and removed en bloc.  Sections of the trachea as well as the azygous, left, right 
apical, right cardiac, and right diaphragmatic lobes of the lung were then embedded with 
paraplast-plus paraffin before being cut into 5 µm slices with a microtome.  Individual sections 
were then placed on glass microscope slides where they were stained according to Harris’ 
hematoxylin and eosin procedure. Following the conclusion of section staining, section mounting 
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was completed by placing a cover slip over the tissue section.  Finally, the slides were examined 
in a “blind” fashion under the light microscope by a veterinary pathologist. 
 
Solutions and Reagents 
 The MKH solution contained (mM):  NaCl (113.0), KCl (4.8), CaCl2 (2.5), KH2PO4 
(1.2), MgSO4 (1.2), NaHCO3 (25.0), and glucose (5.7).  The MKH solution was continuously 
gassed with 95% O2-5% CO2 and maintained at 37oC and a pH of 7.4.  In addition, the 
osmolarity of the MKH solution was 281.2±0.6 mOsm (n = 5; Osmette A Automatic 
Osmometer, Precision Systems, Inc.; Sudbury, MA). 
 All chemical reagents used during the course of this study were purchased from Sigma 
Chemical Co. (St. Louis, MO) and dissolved in saline unless otherwise noted.  Indomethacin was 
prepared in 100 mM sodium carbonate. 
 
Analysis of Results 
 The data obtained from in vitro concentration-response curves examining EpDRF-
induced smooth muscle relaxation were normalized as a percent of the MCh-induced contraction 
while in vitro P MCh concentration-response curves were normalized as a percent of the 
maximum response.  Data normalization was necessary in these instances to avoid large 
variability among P values (Fedan and Frazer, 1992).  Since P is dependent upon the fifth 
power of the radius of the trachea, small differences in the internal diameter of the trachea can 
lead to large variability among P values (Munakata et al., 1989).  Geometric EC50 values were 
derived from the least squares analysis of a sigmoidal curve fit (Sigma Plot®).  When comparing 
EC50 values statistically, normally-distributed EC50 values were used.  The EC50's and maximum 
responses were then analyzed using either the paired or nonpaired Student’s t test, the Mann-
Whitney rank sum test, or one-way repeated measures analysis of variance (ANOVA), as 
appropriate.  For concentration-response curves examining Vms, the EC50's and maximum 
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responses were derived and statistically compared in the same manner as described for the P 
responses. 
 When examining the effect of agents on the Vms, the data were statistically analyzed 
using either the paired or nonpaired Student’s t test or the Mann-Whitney rank sum test, as 
appropriate. 
 For in vivo airway reactivity studies, pre-treatment and post-treatment BF, SRaw, and 
MCh PC200 values among saline- and LPS-treated animals were statistically compared using the 
paired or nonpaired Student’s t test or Mann-Whitney rank sum test, as appropriate.  The effect 
of L-NAME on MCh PC200 values among saline- and LPS-treated animals was compared using 
the paired or nonpaired Student’s t test, as appropriate. 
 All of the results, except where noted, were expressed as the mean ± S.E.M. (standard 
error of the mean) where n is the number of separate experiments.  In every experiment, p < 0.05 
was considered significant. 
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Results 
Effect of LPS-treatment on basal Vms in isolated, perfused trachea 
 LPS-treatment increased the basal Vms in isolated, perfused trachea.  The basal Vms was 
!14.6±1.2 mV and !28.3±1.9 mV for the saline- and LPS-treated groups, respectively (Figure 
26). 
 
Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation in 
isolated, perfused trachea 
 In order to test the hypothesis that LPS-induced alterations in epithelial ion transport 
were associated with perturbations in EpDRF-induced smooth muscle relaxation, smooth muscle 
reactivity to EpDRF was measured in isolated, perfused tracheas from saline- and LPS-treated 
guinea pigs. EpDRF-induced smooth muscle relaxation was stimulated by increasing the tonicity 
of the IL MKH solution with four different osmolytes (NaCl, D-mannitol, urea, and KCl) 
following contraction of the smooth muscle with extraluminally-applied MCh (3×10!7 M; 
~EC50).  Figures 27-29 and Table 1 summarize the results of this study.  When NaCl and D-
mannitol were used to increase the tonicity of the IL bath, EpDRF-induced smooth muscle 
relaxation was potentiated in tracheas from LPS-treated animals (Figure 27).  When urea was 
used, there was no difference in the maximum relaxation responses between the two treatment 
groups; however, there was a small, but significant decrease in smooth muscle reactivity to 
EpDRF in the LPS-treated group, as demonstrated by a rightward shift of the concentration-








Figure 26.  Effect of LPS-treatment on the basal Vms in isolated, perfused trachea.  Basal Vms 
values were obtained from tracheas removed from saline- and LPS-treated animals 18 hr post-
treatment.  Saline- and LPS-treated, n = 20.  *p < 0.05 compared to saline as determined by a 
nonpaired Student’s t test. 
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Figure 27.  Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation elicited with 
IL MKH solution made hypertonic with added (A) NaCl or (B) D-mannitol.  The curves were 
obtained from tracheas removed from saline- and LPS-treated animals 18 hr post-treatment.  The 
preparations were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before NaCl 
or D-mannitol were added in stepwise-increasing, cumulative concentrations to the IL bath.  
EpDRF-induced smooth muscle relaxation was potentiated in tracheas from LPS-treated animals 
when NaCl or D-mannitol were used to evoke EpDRF release.  The osmolyte concentrations 
shown in the abscissa of the figures refer to the osmolar concentrations of osmolyte added to the 
IL MKH solution. Equiosmolar, rather than equimolar, concentrations of NaCl and D-mannitol 
were added to the IL bath.  For NaCl the osmolarity is twice the molarity and for D-mannitol the 
osmolarity is the same as the molarity.  Saline- and LPS-treated, n = 8 for NaCl and n = 6 for D-
mannitol.  *p < 0.05 compared to saline as determined by a nonpaired Student’s t test. 
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Figure 28.  Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation elicited with 
IL MKH solution made hypertonic with added urea.  The curves were obtained from tracheas 
removed from saline- and LPS-treated animals 18 hr post-treatment.  The preparations were 
contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before urea was added in 
stepwise-increasing, cumulative concentrations to the IL bath.  LPS-treatment did not affect the 
maximum relaxation response; however, it caused a small, but significant decrease in smooth 
muscle reactivity to EpDRF, as demonstrated by an increase in the EC50 for relaxation.  (A) and 
(B) are the same data but expressed in a different manner to illustrate the significant difference in 
EC50 values between the treatment groups which is clearly seen in (B).  The data in (B) is 
expressed as a percentage of the maximum relaxation response.  The urea concentrations shown 
in the abscissa of the figures refer to the osmolar concentrations of urea added to the IL MKH 
solution.  For urea the osmolarity is the same as the molarity.  Saline- and LPS-treated, n = 6. 
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Figure 29.  Lack of effect of LPS-treatment on EpDRF-induced smooth muscle relaxation 
elicited with IL MKH solution made hypertonic with added KCl.  The curves were obtained from 
tracheas removed from saline- and LPS-treated animals 18 hr post-treatment.  The preparations 
were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before KCl was added in 
stepwise-increasing, cumulative concentrations to the IL bath.  Neither the maximum relaxation 
response nor the EC50 were affected by LPS-treatment when KCl was used to evoke EpDRF 
release and subsequent smooth muscle relaxation.  The KCl concentrations shown in the abscissa 
of the figure refer to the osmolar concentrations of KCl added to the IL MKH solution.  For KCl 





Effect of LPS-treatment on in vitro airway reactivity to 






(% of MCh)b 
NaCl  
   Saline (8) 11.4 
(8.2-15.8) 
78.2±6.2 




   Saline (6) 15.2 
(8.2-28.2) 
86.1±4.9 




   Saline (6) 10.7 
(9.0-12.9) 
110.3±7.0 













The tracheas were removed from the animals 18 hr post-treatment.  aValues refer to mOsm of 
osmolyte added to the intraluminal MKH solution.  bRelaxation responses in cm H2O were 
normalized as a percentage of the extraluminal MCh (3×10!7 M; ~EC50)-induced contraction.  
cSignificantly greater than saline-treated controls. 
 
80 
Finally, when KCl was used to evoke EpDRF release and subsequent smooth muscle relaxation, 
there was no difference in the concentration-response curves among the saline- and LPS-treated 
groups (Figure 29). 
 
Effect of indomethacin and L-NAME on EpDRF-induced smooth muscle 
relaxation in isolated, perfused trachea from saline- and LPS-treated guinea 
pigs 
 Because LPS is known to up-regulate both inducible cyclooxygenase and nitric oxide 
synthase (Okamoto et al., 1998), the effect of indomethacin, a cyclooxygenase inhibitor, and L-
NAME, a nitric oxide synthase inhibitor, on EpDRF-induced smooth muscle relaxation was 
tested.  This was done to rule out the possible contribution of prostaglandins and NO to the 
potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment.  Neither 
indomethacin nor L-NAME affected EpDRF-induced smooth muscle relaxation when NaCl was 
used to elevate tonicity in isolated, perfused trachea from saline- and LPS-treated guinea pigs 
(Figures 30 and 31). 
 
Effect of LPS-treatment on the epithelial bioelectric events associated with 
EpDRF-induced smooth muscle relaxation 
 A previous study has shown that EpDRF-induced smooth muscle relaxation, elicited by 
hypertonicity, was associated with epithelial bioelectric events, namely a depolarization of the 
Vms (Dortch-Carnes et al., 1999).  The current study has shown that LPS-treatment potentiated 
EpDRF-induced smooth muscle relaxation when NaCl and D-mannitol were used to elicit 
EpDRF release; therefore, according to the hypothesis, the epithelial bioelectric events 




Figure 30.  Lack of effect of extraluminally- and intraluminally-applied indomethacin (3×10!6 
M) on EpDRF-mediated relaxation responses elicited with IL MKH solution made hypertonic 
with added NaCl.  The curves were obtained from tracheas removed from (A) saline- and (B) 
LPS-treated animals 18 hr post-treatment.  Indomethacin was present for 30 min prior to 
contracting the tracheal smooth muscle with extraluminally-applied MCh (3×10!7 M; ~EC50) and 
initiating EpDRF-induced smooth muscle relaxation by adding NaCl in stepwise-increasing, 
cumulative concentrations to the IL bath.  Saline- and LPS-treated, n = 4. 
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Figure 31.  Lack of effect of extraluminally- and intraluminally-applied L-NAME (10!4 M) on 
EpDRF-mediated relaxation responses elicited with IL MKH solution made hypertonic with 
added NaCl.  The curves were obtained from tracheas removed from (A) saline- and (B) LPS-
treated animals 18 hr post-treatment.  L-NAME was present for 30 min prior to contracting the 
tracheal smooth muscle with extraluminally-applied MCh (3×10!7 M; ~EC50) and initiating 
EpDRF-induced smooth muscle relaxation by adding NaCl in stepwise-increasing, cumulative 
concentrations to the IL bath. Saline- and LPS-treated, n = 4. 
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 NaCl concentration-response curves with respect to Vms were generated from isolated, 
perfused tracheas from saline- and LPS-treated animals in the presence of extraluminally-applied 
3×10!7 M MCh (Figure 32).  For an easy comparison of the relationship between hypertonicity-
induced epithelial depolarization and smooth muscle relaxation, depolarization and relaxation 
concentration-response curves were plotted alongside each other as a percentage of the 
maximum depolarization or relaxation, respectively (Figure 33).  In tracheas from LPS-treated 
animals, the IL addition of NaCl significantly increased epithelial depolarization and EpDRF-
induced smooth muscle relaxation compared to the saline-treated controls; however, the Vms of 
each treatment group eventually depolarized to the same level (Figure 32 and Table 2).  In both 
treatment groups, the EC50 for depolarization was significantly greater than the EC50 for EpDRF-
induced smooth muscle relaxation (Figure 33 and Table 2). 
 Besides examining epithelial bioelectric reactivity to NaCl in the presence of 
extraluminally-applied MCh (3×10!7 M), this study also examined epithelial bioelectric 
reactivity to NaCl in the absence of MCh (Figures 34 and 35 and Table 3).  The addition of 
hypertonic NaCl to the EL and IL baths depolarized the Vms in a concentration-dependent 
manner.  In both treatment groups, extraluminally-applied NaCl was more potent than 
intraluminally-applied NaCl.  When comparing responses between the two treatment groups, the 
IL EC50 for depolar-ization was significantly greater in the LPS-treated group compared to the 
saline-treated group.  Finally, extraluminally- and intraluminally-applied NaCl depolarized the 
Vms to a greater extent in the LPS-treated group; however, it did not reach statistical significance, 








Figure 32.  Effect of LPS-treatment on epithelial bioelectric reactivity to hypertonic NaCl in the 
presence of extraluminally-added MCh (3×10!7 M).  The curves were obtained from tracheas 
removed from saline- and LPS-treated animals 18 hr post-treatment.  MCh (3×10!7 M) was 
added to the EL bath before NaCl was added in stepwise-increasing, cumulative concentrations 
to the IL bath. (A) The mV change in the Vms evoked by the addition of IL NaCl.  LPS-treatment 
significantly increased the degree of depolarization while the EC50's were unaffected.  (B) These 
are data from the same experiments in (A); however, they are expressed in a different manner.  
These plots show the actual Vms following the addition of IL NaCl.  In both treatment groups, 
intraluminally-applied NaCl eventually depolarized the Vms to the same level.  Saline- and LPS-




Figure 33.  Effect of LPS-treatment on the relationship between EpDRF-induced smooth muscle 
relaxation and epithelial depolarization elicited by hypertonic NaCl.  The curves were obtained 
from tracheas removed from saline- and LPS-treated animals 18 hr post-treatment.  The 
preparations were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before NaCl 
was added in stepwise-increasing, cumulative concentrations to the IL bath.  This figure 
illustrates that the EC50's for depolarization are significantly greater than the EC50's for relaxation 
in both treatment groups.  Saline- and LPS-treated for relaxation, n = 8 and saline- and LPS-






Relationship between in vitro smooth muscle relaxation and epithelial depolarization 
in isolated, perfused trachea from saline- and LPS-treated guinea pigs 
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The tracheas were removed from the animals 18 hr post-treatment.  aValues refer to mOsm of 
NaCl added to the intraluminal MKH solution.  bRelaxation responses in cm H2O were 
normalized as a percentage of the extraluminal MCh (3×10!7 M; ~EC50)-induced contraction; 
saline- and LPS- treated, n = 8.  cValues refer to the change of the Vms after the administration of 
extraluminal MCh (3×10!7 M); saline- and LPS-treated, n = 4.  dSignificantly greater than saline 




Figure 34.  Effect of LPS-treatment on epithelial bioelectric reactivity to extraluminally- and 
intraluminally-applied NaCl in the absence of MCh (a within-treatment group comparison).  EL 
and IL NaCl concentration-response curves were obtained from tracheas removed from (A) 
saline- and (B) LPS-treated animals 18 hr post-treatment.  NaCl was added in stepwise-
increasing, cumulative concentrations to the EL and IL baths.  In both treatment groups, 
extraluminally-applied NaCl was more potent.  The arrows refer to the fact that the next highest 
concentration of intraluminally-applied NaCl reversed the depolarization, or in other words, 
hyperpolarized the Vms.  In addition, because of the size of the EL bath and the limits of 
solubility of NaCl, only 843.4 mOsm of NaCl could be added.  Saline-treated, n = 7 and LPS-
treated, n = 6. 
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Figure 35.  Effect of LPS-treatment on epithelial bioelectric reactivity to (A) extraluminally- and 
(B) intraluminally-applied NaCl in the absence of MCh (a between-treatment group comparison).  
This is the same data shown in Figure 34 but in a different manner.  EL and IL NaCl 
concentration-response curves were obtained from tracheas removed from saline- and LPS-
treated animals 18 hr post-treatment.  NaCl was added in stepwise-increasing, cumulative 
concentrations to the EL and IL baths.  NaCl depolarized the Vms to a greater extent in the LPS-
treated group; however, it did not reach statistical significance, except for one concentration 
added intraluminally.  The arrows refer to the fact that the next highest concentration of 
intraluminally-applied NaCl reversed the depolarization, or in other words, hyperpolarized the 
Vms.  In addition, because of the size of the EL bath and the limits of solubility of NaCl, only 
843.4 mOsm of NaCl could be added.  Saline-treated, n = 7 and LPS-treated, n = 6.  *p < 0.05 
compared to saline-treated as determined by a nonpaired Student’s t test. 
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TABLE 3 
Effect of LPS-treatment on in vitro epithelial bioelectric reactivity to 
hypertonic NaCl in isolated, perfused trachea 
 
 
                        
EC50 (mOsm)a 
(95% C.I.) 
   Treatment (n) EL IL 









EL, extraluminal; IL, intraluminal.  The tracheas were removed from the animals 18 hr post-
treatment.  aValues refer to mOsm of NaCl added to the extraluminal or intraluminal MKH 
solution.  bSignificantly greater than saline (EL).  cSignificantly greater than LPS (EL).  
dSignificantly greater than saline (IL). 
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Effects of indomethacin and L-NAME on LPS-induced alterations of the basal 
Vms in isolated, perfused trachea 
 In order to elucidate the mechanism underlying the increase in the basal Vms following 
LPS-treatment, the effect of indomethacin (3×10!6 M) and L-NAME (10!4 M) on the basal Vms 
was examined.  Both indomethacin and L-NAME were chosen because LPS up-regulates their 
targets, cyclooxygenase and nitric oxide synthase (Okamoto et al., 1998) whose products, 
prostaglandins and NO, respectively, have been shown to stimulate Cl! secretion (Tamaoki et al., 
1992; Tamai and Gaginella, 1993). 
 Indomethacin depolarized the Vms in both treatment groups (Figure 36), but significantly 
more so in the LPS-treated group:  +3.1±0.5 mV and +5.5±0.7 mV for the saline- and LPS-
treated groups, respectively (p < 0.05). 
 L-NAME slightly hyperpolarized the Vms in both treatment groups (Figure 37); however, 
there was no significant difference between the magnitude of the hyperpolarization among the 
saline- and LPS-treated groups. 
 Because L-NAME has been shown to possess muscarinic receptor antagonist properties 
(Buxton et al., 1993), the effect of atropine (10!6 M), a muscarinic receptor antagonist, on the 
basal Vms was characterized to determine if the small effect of L-NAME was due to the 








Figure 36.  Effect of indomethacin on the basal Vms of isolated, perfused trachea from saline- 
and LPS-treated animals.  The tracheas were removed from saline- and LPS-treated animals 18 
hr post-treatment.  Following a 3 hr equilibration period, indomethacin (3×10!6 M) was 
simultaneously added to the EL and IL baths.  (A) The actual mV change in the basal Vms 
evoked by the addition of indomethacin.  The depolarizing effect of indomethacin was 
significantly greater in the LPS-treated group.  (B) In the presence of indomethacin, the Vms was 
significantly decreased in both treatment groups.  Saline- and LPS-treated, n = 5.  *p < 0.05 
compared to saline-treated as determined by a nonpaired Student’s t test.  †p < 0.05 compared to 
saline-treated (!Indomethacin) as determined by a paired Student’s t test.  ††p < 0.05 compared 
to saline-treated (!Indomethacin) as determined by a nonpaired Student’s t test.  †††p < 0.05 
compared to LPS-treated (!Indomethacin) as determined by a paired Student’s t test. 
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Figure 37.  Effect of L-NAME on the basal Vms of isolated, perfused trachea from saline- and 
LPS-treated animals.  The tracheas were removed from saline- and LPS-treated animals 18 hr 
post-treatment.  Following a 3 hr equilibration period, L-NAME (10!4 M) was added 
simultaneously to the EL and IL baths.  (A) The actual mV change in the Vms evoked by the 
addition of L-NAME.  There was no difference in the hyperpolarizing effect of L-NAME 
between the treatment groups.  (B) There was no difference in the Vms before and after the 
addition of L-NAME within each treatment group.  Saline- and LPS-treated, n = 4.  *p < 0.05 
compared to saline-treated (!L-NAME) as determined by a nonpaired Student’s t test.  †p < 0.05 
compared to saline-treated (+L-NAME) as determined by a nonpaired Student’s t test. 
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 The effect of atropine on the basal Vms in isolated, perfused trachea from saline- and LPS-
treated animals is shown in Figure 38.  Atropine’s effect was variable in both treatment groups.  
Atropine initiated either a depolarization or a hyperpolarization of the Vms which did not exceed 
±2 mV. 
 Since atropine did not clarify the effects of nitric oxide and its possible contribution to 
the basal Vms, the effect of sodium nitroprusside (SNP), a nitric oxide donor, on the basal Vms of 
isolated, perfused trachea from saline- and LPS-treated animals was determined (Figure 39).  
SNP (10!6 M) caused a very small depolarization of the basal Vms; however, there was no 
difference in the magnitude of the depolarization among the treatment groups. 
 
Effect of amiloride on LPS-induced alterations of the basal Vms in isolated, 
perfused trachea 
 Since the effects of indomethacin and L-NAME gave little insight into the mechanism 
responsible for the increased basal Vms in tracheas from LPS-treated animals, the Na+ channel 
blocker, amiloride, was used (Figure 40).  Amiloride was chosen because its target plays an 
important role in epithelial ion transport (Figure 6).  The application of amiloride (3×10!5 M) to 
the IL surface of isolated, perfused tracheas from saline- and LPS-treated animals depolarized 
the Vms, but significantly more so in the LPS-treated group.  After the addition of amiloride, 









Figure 38.  Effect of atropine on the basal Vms of isolated, perfused trachea from (A) saline- and 
(B) LPS-treated animals.  The tracheas were removed from saline- and LPS-treated animals 18 
hr post-treatment.  Following a 3 hr equilibration period, atropine (10!6 M) was added 
simultaneously to the EL and IL baths.  In both groups, atropine had variable effects, sometimes 
depolarizing and other times hyperpolarizing.  Since there was no consistent effect, the raw data 
from four individual experiments was plotted and an average value shown underneath each 
graph.  Saline- and LPS-treated, n = 4. 
95 
 
Figure 39.  Effect of SNP on the basal Vms of isolated, perfused trachea from saline- and LPS-
treated animals.  The tracheas were removed from saline- and LPS-treated animals 18 hr post-
treatment.  Following a 3 hr equilibration period, SNP (10!6 M) was added to the EL and IL 
baths.  (A) The actual mV change in the basal Vms evoked by the addition of SNP.  There was no 
significant difference between the degree to which SNP depolarized the Vms among the treatment 
groups.  (B) There was no difference in the Vms before and after the addition of SNP within each 
treatment group.  Saline- and LPS-treated, n = 3.  *p < 0.05 compared to saline-treated (!SNP) 
as determined by a nonpaired Student’s t test.  †p < 0.05 compared to saline-treated (+SNP) as 
determined by a nonpaired Student’s t test. 
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Figure 40.  Effect of amiloride on the basal Vms of isolated, perfused trachea from saline- and 
LPS-treated animals.  The tracheas were removed from saline- and LPS-treated animals 18 hr 
post-treatment.  Following a 3 hr equilibration period, amiloride (3×10!5 M) was added to the IL 
bath.  (A) The actual mV change in the basal Vms evoked by the addition of amiloride.  The 
depolarizing effect of amiloride was significantly greater in the LPS-treated group.  (B) 
Amiloride significantly altered the Vms in both treatment groups.  After the IL application of 
amiloride, there was no longer a difference between the Vms’s among the two groups.  Saline- 
and LPS-treated, n = 5.  *p < 0.05 compared to saline-treated as determined by a nonpaired 
Student’s t test.  †p < 0.05 compared to saline-treated (!Amiloride) as determined by a paired 
Student’s t test.  ††p < 0.05 compared to saline-treated (!Amiloride) as determined by a 
nonpaired Student’s t test.  †††p < 0.05 compared to LPS-treated (!Amiloride) as determined by 




Effect of the in vitro addition of LPS on the basal Vms of isolated, perfused 
trachea from naive animals 
 Because this study has shown that in vivo LPS-treatment (4 mg/kg, i.p; 18 hr post-
treatment) significantly hyperpolarized the basal Vms (Figure 26), it was of interest to investigate 
whether or not the in vitro application of LPS to the organ bath did the same.  The addition of 
LPS (10 µg/ml) to the EL and IL surfaces of isolated, perfused trachea from naive guinea pigs 
caused a nearly significant (p = 0.055) hyperpolarization of the basal Vms when compared to the 
control preparation to which nothing was added (Figure 41).  In the untreated, control 
preparation, the reported Vms was due to a slight hyperpolarization of the Vms over time which 
is inherent to the tissue.  In addition, LPS caused a significant change in the basal Vms when 
compared to the Vms in the absence of LPS. 
 
Effect of LPS-treatment on in vitro airway reactivity to MCh in epithelium-
intact and -denuded isolated, perfused trachea 
 Previous studies have shown that increases and decreases in EpDRF-induced smooth 
muscle relaxation were associated with alterations in in vitro and in vivo airway reactivity to 
MCh (Lawrence et al., 1996; Fedan et al., 2000).  In this study LPS-treatment was shown to alter 
EpDRF-induced smooth muscle relaxation; therefore, it is hypothesized that in vitro and/or in 
vivo airway reactivity to MCh should be altered in accordance with the aforementioned studies. 
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Figure 41.  Effect of the in vitro addition of LPS on the basal Vms of isolated, perfused trachea 
from naive animals.  Following a 3 hr equilibration period, LPS (10 µg/ml) was simultaneously 
added to the EL and IL baths.  (A) The hyperpolarizing effect of LPS on the basal Vms reached a 
nearly significant level when compared to the untreated, control preparation.  The reported Vms 
for the untreated, control preparation was due to a slight hyperpolarization of the Vms over time 
which was inherent to the tissue.  (B) There was a significant difference between the Vms’s 
before and after the addition of LPS.  t = 0 hr refers to the time immediately before the start of 
the control- or LPS-treatment period.  t = x hr refers to the length of the control- or LPS-
treatment period which was dependent upon the time required for the response to LPS to 
equilibrate, and the length of this period was variable between tracheas.  Control- and LPS-
treated, n = 5.  †p = 0.055 compared to control-treated as determined by a nonpaired Student’s t 
test.  *p < 0.05 compared to !LPS as determined by a paired Student’s t test. 
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 In epithelium-intact tracheas, there was no difference in reactivity to extraluminally- and 
intraluminally-applied MCh between the two treatment groups; however, the tracheas from both  
treatment groups were more sensitive to extraluminally-applied MCh (Figure 42A, Table 4).  In 
addition, there was no difference in the IL/EL maximum response ratio between the saline- and 
LPS-treated groups. 
 In epithelium-denuded tracheas, the differences between EL and IL reactivity to MCh 
were abolished, and the IL/EL maximum response ratio approached unity (Figure 42B, Table 5).  
In addition, there was no difference in reactivity to extraluminally- and intraluminally-applied 
MCh in epithelium-denuded tracheas from saline- and LPS-treated animals. 
 
Effect of LPS-treatment on tracheal epithelial bioelectric reactivity 
to MCh in isolated, perfused trachea 
 Although LPS-treatment did not affect in vitro smooth muscle reactivity to MCh in 
epithelium-intact and -denuded isolated, perfused tracheas, it had a profound effect upon tracheal 
epithelial bioelectric reactivity to MCh. 
 In tracheas from both saline- and LPS-treated animals, extraluminally-applied MCh 
produced a biphasic concentration-response curve (Figure 43 and Table 6).  At MCh 
concentrations less than 10!6 M, the Vms hyperpolarized while at MCh concentrations greater 
than 10!6 M, the Vms depolarized.  The EC50's and maximum responses for hyperpolarization 
were smaller and larger, respectively, in the LPS-treated group; however, the MCh EC50's and 
maximum responses for depolarization were not different.  The IL application of MCh also 
generated biphasic electrical concentration-response curves in both treatment groups 
(hyperpolarizing at MCh concentrations less than 10!3 M and depolarizing at MCh 





Figure 42.  Lack of effect of LPS-treatment on tracheal smooth muscle reactivity to 
extraluminally- and intraluminally-applied MCh in (A) epithelium-intact and (B) -denuded 
isolated, perfused trachea. EL and IL MCh concentration-response curves were obtained from 
tracheas removed from saline- and LPS-treated animals 18 hr post-treatment.  In epithelium-
intact tracheas from saline- and LPS-treated animals, extraluminally-applied MCh was more 
potent.  Removal of the epithelium abolished the difference between reactivity to extraluminally- 





Effect of LPS-treatment on in vitro airway reactivity to 










Treatment (n) EL IL EL IL  




10.7±1.5 8.4±1.1c 0.78±0.03 




6.6±0.9 4.7±0.9e 0.70±0.12 
 
EL, extraluminal; IL, intraluminal.  The tracheas were removed from the animals 18 hr post-
treatment.  aThe IL/EL maximum response ratio is used to gauge the modulatory effect of the 
epithelium on the EL and IL maximum contractile responses.  In the absence of the epithelium, 
the ratio is unity while it becomes less than unity in the presence of the epithelium.  As the 
modulatory effect of the epithelium becomes more inhibitory, the ratio becomes smaller (Fedan 
and Frazer, 1992; Fedan et al., 2000).  bSignificantly greater than saline (EL). cSignificantly less 






Effect of LPS-treatment on in vitro airway reactivity to 












Treatment (n) EL IL EL IL  




3.8±0.7 3.5±0.6 0.97±0.12 




3.9±0.4 3.5±0.3 1.00±0.06 
 
EL, extraluminal; IL, intraluminal.  The tracheas were removed from the animals 18 hr post-
treatment.  aThe IL/EL maximum response ratio is used to gauge the modulatory effect of the 
epithelium on the EL and IL maximum contractile responses.  In the absence of the epithelium, 
the ratio is unity while it becomes less than unity in the presence of the epithelium.  As the 
modulatory effect of the epithelium becomes more inhibitory, the ratio becomes smaller (Fedan 





In the case of intraluminally-applied MCh, the maximum hyperpolarization response was greater 
in the LPS-treated group with respect to the saline-treated controls while there was no difference 
in the depolarization responses among the two treatment groups. 
 
Effect of LPS-treatment on in vivo pulmonary function and airway reactivity 
to MCh 
 Besides investigating whether or not LPS-treatment altered in vitro airway reactivity to 
MCh in the isolated, perfused trachea, this study also investigated whether or not LPS-treatment 
altered in vivo airway reactivity to inhaled, MCh aerosol. 
 The post-treatment saline BF was slightly, but significantly, less than the pre-treatment 
value; however, there were no other differences between the pre- or post-treatment SRaw or BF 
values within each treatment group (Figure 44). 
 Eighteen hr following saline-treatment, the animals’ reactivity to inhaled, MCh aerosol 
increased which was demonstrated by a decrease in the MCh PC200 (Figure 45 and Table 7).  On 
the other hand, LPS-treatment failed to produce any changes in airway reactivity to MCh when 
the LPS pre-and post-treatment groups were compared; however, when comparing the saline and 
LPS post-treatment groups to allow for the increase in reactivity in the saline-treated group, the 
LPS-treated animals were 3-fold hyporeactive to the effects of inhaled MCh as determined by a 





Figure 43.  Effect of LPS-treatment on epithelial bioelectric reactivity to (A) extraluminally- and 
(B) intraluminally-applied MCh in isolated, perfused trachea.  EL and IL MCh concentration-
response curves were obtained from tracheas removed from saline- and LPS-treated animals 18 
hr post-treatment.  The results were expressed as changes in the transepithelial potential 
difference ( Vms).  Positive values refer to depolarization of the Vms while negative values refer 
to hyperpolarization of the Vms.  In both groups, extraluminally-applied MCh was more potent.  
Saline-treated, n = 7 and LPS-treated, n = 6.  *p < 0.05 compared to saline-treated controls as 




Effect of LPS-treatment on in vitro epithelial bioelectric reactivity to 
MCh in isolated, perfused trachea 
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EL, extraluminal; IL, intraluminal.  The tracheas were removed from the animals 18 hr post-
treatment.  aValues refer to the change in the Vms.  bSignificantly greater than saline (EL).  
cSignificantly less than saline (EL).  dSignificantly greater than LPS (EL).  eSignificantly greater 





Figure 44.  Effect of saline- and LPS-treatments on post-treatment basal (A) specific airway 
resistance (SRaw) and (B) breathing frequency (BF).  Eighteen hr following saline- and LPS-
treatments, basal SRaw and BF were measured.  There was a slight, but significant, decrease in 
the saline post-treatment BF when compared to the pre-treatment value.  There were no other 
differences between the pre- and post-treatment values.  Saline- and LPS-treated, n = 6.  *p < 
0.05 compared to saline pre-treatment as determined by a paired Student’s t test. 
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Figure 45.  Effect of (A) saline- and (B) LPS-treatments on in vivo airway reactivity to inhaled 
MCh aerosol.  Eighteen hr post-treatment, (A) the reactivity of the saline-treated animals to 
inhaled, MCh aerosol increased while (B) LPS-treatment had no significant effect on airway 
reactivity.  When comparing the saline- and LPS-treated groups to allow for the increase in 
reactivity of the saline-treated group, the LPS-treated animals were hyporeactive to the effects of 




Effect of saline- and LPS-treatments on in vivo airway 
reactivity to inhaled MCh 
 MCh PC200 (mg/ml) 
(95% C.I.) 
Treatment (n) Pre-treatment Post-treatment 









aSignificantly less than saline (pre-treatment).  bSignificantly greater than saline (post-treatment). 
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Effect of L-NAME on in vivo airway reactivity to MCh in saline- and LPS-
treated animals 
 In order to determine if an acquired NO component contributed to the in vivo airway 
hyporeactivity of the LPS-treated animals, the effect of an L-NAME aerosol on in vivo airway 
reactivity to MCh was determined in saline-and LPS-treated animals.  Prior to the generation of 
in vivo MCh concentration-response curves in the presence of L-NAME, the LPS-treated animals 
were again found to be hyporeactive to the effects of inhaled MCh as demonstrated by a 
comparison of MCh PC200 values from saline- and LPS-treated animals (Figure 46 and Table 8).  
The administration of L-NAME prior to MCh had no effect upon airway reactivity in either the 
saline- or LPS-treated animals. 
 
Histological Examination of Guinea-Pig Airways Following LPS-Treatment 
 Since L-NAME failed to provide any clues to the mechanism underlying LPS-induced in 
vivo airway hyporeactivity to MCh, this study then examined the effects of LPS-treatment on the 
microscopic structure of various regions of the guinea-pig respiratory tract.  This was done to 
determine if LPS-treatment altered the physical structure of the airways in such a way as to limit 
access of MCh to the airway smooth muscle (i.e., excessive mucus secretion, epithelial and 
basement membrane hyperplasia and/or hypertrophy, etc.). Histological sections of the distal 
trachea as well as the azygous, left, right apical, right cardiac, and right diaphragmatic lobes of 
the lung from saline- and LPS-treated animals were examined.  The sections from both treatment 







Figure 46.  Lack of effect of L-NAME on in vivo airway reactivity to inhaled MCh aerosol in 
(A) saline- and (B) LPS-treated guinea pigs.  Eighteen hr post-treatment, L-NAME did not alter 





Effect of L-NAME on in vivo airway reactivity to 
inhaled MCh in saline- and LPS-treated guinea pigs 
 MCh PC200 (mg/ml) 
(95% C.I.) 
Treatment (n) !L-NAME +L-NAME 









aSignificantly greater than saline (!L-NAME). 
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Representative sections of the distal trachea and left lobe of the lung from saline- and LPS-
treated animals are shown in Figure 47A-F.  The bronchial and tracheal epithelium as well as the 
alveolar sacs remained structurally intact within each group.  Finally, in both treatment groups, a 
few inflammatory cells, namely eosinophils and neutrophils, could be seen infiltrating the 




Figure 47.  Histological sections of guinea-pig airways following saline- and LPS-treatments. 
Representative Harris’ hematoxylin-eosin stained histological sections from saline (A, C, and E)- 
and LPS (B, D, and F)-treated animals made 18 hr post-treatment.  A thorough examination of 
histological sections from saline- and LPS-treated animals showed that LPS-treatment did not 
alter airway appearance or structure, at least at the level of the light microscope.  A and B are 
40× sections of distal trachea, C and D are 10× sections of bronchi, and E and F are 20× sections 
of the alveolar regions from saline- and LPS-treated animals, respectively.  Sections of the 
bronchi and alveolar regions were taken from the left lobe of the lung.  The measurement bars 
(50, 200, and 100 µm) found in B, D, and F also pertain to their respective counterpart in A, C, 
and E.  These results are representative of eight different experiments from each treatment group. 
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Discussion 
 There are three general conclusions which can be drawn from the results of this study. 
First, the effects of EpDRF on the airway smooth muscle are associated with changes in the 
electrical activity of the airway epithelium following LPS-treatment; however, these changes in 
the effects of EpDRF are dependent upon the osmolyte used to elicit EpDRF release.  Secondly, 
epithelial depolarization does not always precede EpDRF-induced smooth muscle relaxation, 
suggesting that EpDRF release is not always dependent on epithelial depolarization.  Finally, 
LPS-induced in vivo airway hyporeactivity to inhaled, MCh aerosol may be due, at least in part, 
to an increase in the actions of EpDRF. 
 Both in vivo and in vitro LPS-treatment significantly hyperpolarized the basal Vms of 
isolated, perfused trachea.  To our knowledge, there have been very few studies examining the 
effect of LPS on ion channel and/or transporter function; however, those studies which have 
examined this phenomenon aid in the explanation of our results.  In rat tail artery smooth muscle 
cells, LPS increased the inward flux of Ca2+ ions through voltage-sensitive Ca2+ channels 
(Wilkinson et al., 1996) while two other, separate studies reported that LPS increased the 
conductance of Ca2+-activated K+ channels in vascular smooth muscle cells 
(Miyoshi and Nakaya, 1994; Hoang et al., 1997).  In our system, LPS or one of its mediators 
may be increasing epithelial cell Ca2+ influx which could activate Ca2+-activated K+ channels 
found on the basolateral surface of the airway epithelium (Clarke and Boucher, 1993).  It is 
intriguing to note that Ca2+-activated K+ channels have been shown to be involved in the 
synthesis and/or release of EpDRF (Tamaoki et al., 1997), and their activation by LPS or one of 
its many mediators may account for the alterations in EpDRF-induced smooth muscle relaxation 
following LPS-treatment. 
 The alteration of EpDRF-induced smooth muscle relaxation following LPS-treatment 
was dependent upon the osmolyte used to elevate IL tonicity, suggesting that the synthesis, 
release, and/or effects of EpDRF are osmolyte-dependent, at least after LPS-treatment.  It is 
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difficult to reconcile these results with the fact that EpDRF-induced smooth muscle relaxation is 
initiated regardless of the osmolyte used to elevate EL or IL tonicity 
(Munakata et al., 1988; Fedan et al., 1999).  One study has examined the potency of different 
osmolytes to elicit EpDRF-induced smooth muscle relaxation.  This study reported that NaCl and 
KCl were equipotent in their ability to evoke EpDRF-induced smooth muscle relaxation; 
however, no other agents were examined (Fedan et al., 1999).  The differences among the 
osmolytes used in the present study could be due to their ability or inability to interact with 
specific epithelial ion channels and/or transporters, namely apical Na+ and Cl! channels, which 
seem to be involved in EpDRF-induced smooth muscle relaxation (Fedan et al., 1999).  D-
mannitol is membrane-impermeable so it would be unable to pass through any ion channel 
and/or transporter while urea is freely, membrane-permeable.  On the other hand, both NaCl and 
KCl can enter the cell through their respective ion channels and/or transporters.  In addition, this 
study showed that LPS-treatment altered the basal bioelectric properties of the epithelium which 
could further modify EpDRF-induced smooth muscle relaxation in response to these osmolytes if 
a specific ion channel and/or transporter involved in these relaxation responses were altered 
following LPS-treatment.  It is of interest to note that a previous study examined the effects of 
NaCl, mannitol, and urea on isolated, human bronchial strips, and they reported that hypertonic 
NaCl and mannitol initiated bronchoconstriction while urea did not (Jongejan et al., 1990).  As a 
side note, the contractile responses elicited by these osmolytes may be attributed to species 
differences or more importantly to the fact that one cannot selectively add pharmacological 
agents to either the serosal or mucosal surfaces of strip preparations.  Although our study looked 
at EpDRF-induced smooth muscle relaxation elicited by these agents, our study and that of 
Jongejan et al. (1990) demonstrated that hypertonic NaCl and D-mannitol behave in a similar 
manner regardless of the endpoint, contraction or relaxation, examined.  In our study, NaCl and 
D-mannitol seem to be working by a similar mechanism while urea and KCl act by a different 
mechanism from each other as well as from NaCl and D-mannitol following LPS-treatment. 
116 
 We investigated whether the potentiation of EpDRF-induced smooth muscle relaxation, 
elicited by NaCl, following LPS-treatment was due to an acquired NO and/or prostanoid 
component because both NO and certain prostanoids are known smooth muscle relaxants 
(Folkerts and Nijkamp, 1998). In addition, LPS can up-regulate inducible nitric oxide synthase as 
well as potentiate the smooth muscle relaxant effects of some prostanoids in guinea pigs 
(Stein et al., 1996; Myers et al., 1999).  Both L-NAME and indomethacin, inhibitors of nitric 
oxide synthase and cyclooxygenase, respectively, failed to have any effect upon EpDRF-induced 
smooth muscle relaxation in tracheas from saline- and LPS-treated animals.  This further 
supports the conclusion that EpDRF is neither NO nor a prostanoid and that the potentiation of 
EpDRF-induced smooth muscle relaxation following LPS-treatment was not due to an acquired 
NO or prostanoid component. 
 The potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment 
was also associated with a potentiation of the epithelial bioelectric events, depolarization of the 
Vms, preceding EpDRF-induced smooth muscle relaxation when NaCl was used to elevate IL 
tonicity.  These results further strengthen the hypothesis that the two events are functionally 
linked.  Both hypertonicity-induced smooth muscle relaxation and epithelial depolarization were 
potentiated following LPS-treatment; however, in both treatment groups, the epithelium more 
readily released EpDRF than depolarized in response to elevated mucosal tonicity.  The 
epithelium can release EpDRF, as demonstrated by smooth muscle relaxation, when as little as 
0.84 mOsm of NaCl was added to the IL surface of the trachea; however, the Vms did not 
depolarize in response to hypertonicity until approximately 8.44 mOsm of added NaCl.  If 
epithelial depolarization in response to hypertonicity signaled the release of EpDRF 
(Dortch-Carnes et al., 1999), we would have expected the epithelium to depolarize prior to every 
relaxation response; however, this was clearly not the case.  Because of this discrepancy, it is 
tempting to speculate that two events are taking place.  At low concentrations of hypertonicity, 
EpDRF release is independent of epithelial depolarization, a situation analogous to 
pharmacomechanical coupling.  As EpDRF is released in response to higher concentrations of 
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hypertonicity, epithelial depolarization may be a necessary component to signal the release of 
greater quantities of EpDRF, a situation analogous to electromechanical coupling. 
 Alternatively, transepithelial depolarization may be quite, simply a coincident, 
epiphenomenon occurring in parallel with another signal (i.e., change in intracellular pH) that is 
more sensitive to osmolarity changes.  It is quite possible that changes in intracellular pH, and 
not transepithelial depolarization, in response to elevated mucosal or serosal tonicity is the signal 
for the synthesis, release, and/or effects of EpDRF.  This is a potential avenue of further 
investigation given the fact that exposure of cells to hyperosmotic solution causes cell 
alkalinization (Miyata et al., 2000).  In addition, the Na+ channel blocker, amiloride, and the 
Cl!channel blocker, DIDS, which attenuate EpDRF-induced smooth muscle relaxation, are also 
capable of inhibiting the Na+-H+ exchanger and the Cl!-HCO3! exchanger (Kreydiyyeh, 2000; 
Lamb et al., 2000); respectively.  The actions of these pharmacological inhibitors on their 
respective targets would, without a doubt, profoundly influence intracellular pH. 
 This study also examined epithelial bioelectric reactivity to hypertonic NaCl in tracheas 
from saline- and LPS-treated animals.  These experiments were done in the absence of MCh 
since smooth muscle contraction was not a necessary component of these experiments.  In both 
treatment groups, the epithelium depolarized in response to extraluminally- and intraluminally-
applied NaCl with the EL surface of the trachea being more sensitive to hypertonicity.  This was 
in contrast to another study examining the effect of hypertonicity on airway epithelial bioelectric 
responses, in which cultured, human nasal epithelial cells depolarized only when hypertonic 
mannitol was added to the apical surface of the epithelium (Willumsen et al., 1994).  This 
discrepancy may be attributed to species or regional differences in ion transport 
(Boucher et al., 1980).  Tracheas from LPS-treated animals were also less sensitive to the effects 
of intraluminally-applied NaCl than those from saline-treated animals.  Because the basal Vms in 
tracheas from LPS-treated animals was significantly more hyperpolarized, it may be more 
difficult to depolarize the Vms or the ion channels and/or transporters affected by hypertonicity 
could be less sensitive to the effect of IL hypertonicity following LPS-treatment.  Overall, these 
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results demonstrate that the EL and IL surfaces of the trachea can function as an osmotic sensor, 
with the EL surface being more sensitive.  In addition, LPS-treatment alters the ability of the IL 
surface to act as an osmotic sensor. 
 This study investigated the mechanism(s) behind the hyperpolarization of the Vms 
following LPS-treatment by examining the effect of various pharmacological agents on the Vms.  
Because LPS is known to up-regulate inducible nitric oxide synthase and cyclooxygenase, the 
effect of their inhibitors on the basal Vms was examined.  The small hyperpolarization of the Vms 
by L-NAME in both treatment groups was not consistent with the reported effects of NO on ion 
transport.  In rat colon and human airway epithelial cells, NO stimulated Cl! secretion 
(Tamai and Gaginella, 1993; Kamosinska et al., 1997).  If NO stimulates Cl! secretion in our 
system, L-NAME, by virtue of its ability to inhibit NO synthesis, should have depolarized the 
Vms which was clearly not the case.  Sodium nitroprusside, a NO donor, depolarized the Vms, 
which was not consistent with a previous report demonstrating its ability to stimulate Cl! 
secretion (Tamai and Gaginella, 1993).  Our results, however, were internally consistent.  Since 
L-NAME hyperpolarized the Vms in our system, we would have expected a NO donor such as 
sodium nitroprusside to depolarize the Vms.  From both of these experiments, however, we can 
conclude that NO makes an insignificant contribution to the generation of the Vms in tracheas 
from either saline- or LPS-treated animals. 
 Because L-NAME has muscarinic antagonist properties (Buxton et al., 1993), we 
investigated the effects of atropine, a nonspecific muscarinic receptor antagonist, on the basal 
Vms in both treatment groups.  The variable effects of atropine on the Vms observed in this study 
were not consistent with another study which reported that atropine profoundly and rapidly 
depolarized the Vms of rabbit trachea in vivo (Tamaoki et al., 1996).  The variable effects of 
atropine seen in this study could have resulted from the antagonism of different muscarinic 
receptor subtypes, some of which may be more prevalent in one animal than another.  This is a 
reasonable conclusion given the fact that this study has shown that at least two populations of 
muscarinic receptor subtypes exist in the guinea-pig tracheal epithelium which are capable of 
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initiating opposite electrophysiological effects.  The fact that atropine does have an 
electrophysiological effect suggests that the nerves endings embedded in the airway wall are 
tonically releasing ACh, which exerts its effect by binding to epithelial muscarinic receptors.  
From our results with atropine, the true effect of L-NAME cannot be deciphered; however, a 
more rigorous, future study should use equieffective concentrations of atropine and L-NAME 
with respect to their muscarinic antagonist properties. 
 Unlike L-NAME, the electrophysiological effects of indomethacin reported in this study 
were consistent with other studies in the literature.  Two prostaglandins in particular, D2 and E2, 
have been shown to stimulate Cl! secretion in several unrelated species 
(Tamaoki et al., 1992a,b; Saunders et al., 1993; Bourke et al., 1995).  Indomethacin depolarized 
the Vms in both treatment groups, but significantly more so in the LPS-treated group.  The 
depolarizing effects of indomethacin were consistent with an inhibition of prostanoid-stimulated 
Cl! secretion.  The fact that indomethacin depolarized the Vms to a greater extent in the LPS-
treated group suggests that prostanoids contribute more to the generation of the basal Vms 
following LPS-treatment and/or their effects were potentiated by changes in their receptor or 
post-receptor signaling.  In addition, this suggests that prostanoid-stimulated Cl! secretion may 
contribute to the significant hyperpolarization of the Vms after LPS treatment. 
 The addition of amiloride to the IL surface of the trachea abolished the difference 
between the Vms’s among the two treatment groups.  This strongly suggests that the 
hyperpolarization of the Vms following LPS-treatment was due to an increase in amiloride-
sensitive Na+ transport or Na+ transport in general.  An increase in Na+ removal from the lumen, 
via these channels, would generate a more negative Vms.  Because the airway epithelium consists 
of numerous ion channels and transporters, alterations in any of them (Figure 6) could explain 
changes in the Vms following LPS-treatment.  For example, an increase in the number and/or 
activity of the Na+-K+-ATPase would increase amiloride-sensitive Na+ transport and 
subsequently hyperpolarize the Vms.  More systematic experiments which would take advantage 
of patch clamping and transepithelial resistance and Isc measurements, and other ion channel and 
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transporter inhibitors would be necessary to determine the mechanism responsible for LPS-
induced hyperpolarization of the Vms.  These results with amiloride also impact on the possible 
mechanism(s) underlying the potentiation of EpDRF-induced smooth muscle relaxation 
following LPS-treatment.  If amiloride-sensitive Na+channels increase in number and/or activity 
following LPS-treatment, this may potentiate EpDRF-induced smooth muscle relaxation 
inasmuch as their inhibition significantly attenuates this response (Fedan et al., 1999). 
 The potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment 
was associated with in vivo airway hyporeactivity to inhaled, MCh aerosol while no differences 
in in vitro airway reactivity to MCh existed in isolated, perfused tracheas from saline- and LPS-
treated animals. Over the years, there have been several, inconsistent reports concerning the 
effect of LPS-treatment on in vitro and in vivo guinea-pig airway reactivity.  In vivo, some 
studies have reported hyperreactivity (Oosterhout et al., 1991), hyporeactivity 
(Folkerts et al., 1988), and no change (Fedan et al., 1995) in guinea-pig airway reactivity to 
contractile agonists.  The same can be said for in vitro airway reactivity as well.  Again, some 
studies have reported hyperreactivity to contractile agonists (ACh, histamine, arecoline) 
(Folkerts et al., 1989; Yamawaki et al., 1990; Oosterhout et al., 1991), hyporeactivity 
(Folkerts et al., 1988), and finally, others have shown no change (Fedan et al., 1995) in in vitro 
guinea-pig airway reactivity.  In our study, there were no differences in airway reactivity to MCh 
in epithelium-intact and -denuded isolated, perfused tracheas.  This is consistent with a previous 
study in our laboratory (Fedan et al., 1995) even though the 18 hr post-treatment time point was 
not examined.  In vivo, LPS-treated guinea pigs were hyporeactive to the effects of inhaled, MCh 
aerosol.  This is not consistent with the earlier, published reports from our laboratory, but again 
the 18 hr post-treatment time point was not examined which may account for the difference 
(Fedan et al., 1995). An acquired NO component does not seem to be responsible for the 
hyporeactivity to MCh following LPS-treatment in our study since inhaled, L-NAME aerosol 
was without effect on in vivo airway reactivity to MCh in LPS-treated animals. 
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 In the previous study reporting in vivo airway hyporeactivity to histamine following LPS-
treatment (Folkerts et al., 1988), the airways of these guinea pigs were infiltrated with large 
numbers of neutrophils and monocytes; however, there were no signs of pulmonary 
inflammation following LPS-treatment in our study.  This was probably due to the fact that the 
guinea pigs in the previous study were exposed to LPS by inhalation and examined 24 hr post-
treatment while our animals were given LPS i.p. and examined 18 hr post-treatment.  The lack of 
pulmonary inflammation in our LPS-treated guinea pigs suggests that changes in airway 
reactivity are not necessarily accompanied by airway inflammation.  The airway hyporeactivity 
following LPS-treatment does not seem to be due to an acquired NO component or alterations in 
the physical structure of the airways but may be due, at least in part, to an increase in the actions 
of EpDRF.  In vivo changes in airway reactivity did not manifest themselves in vitro which 
suggests that the mechanism responsible for in vivo hyporeactivity to MCh did not involve the 
trachea or was lost in vitro. 
 This is not the first time that alterations in the actions of EpDRF have been accompanied 
by changes in in vivo and/or in vitro airway reactivity.  For example, exposure to ozone causes a 
decrease in the actions of EpDRF which is associated with in vivo and in vitro airway 
hyperreactivity to MCh (Fedan et al., 2000).  In addition, sensitization and challenge of guinea 
pigs with ovalbumin potentiates EpDRF-induced smooth muscle relaxation which is 
accompanied by in vitro airway hyporeactivity to MCh, but paradoxically, these animals are 
hyperreactive to MCh in vivo (Lawrence et al., 1996).  Now, with the addition of our study, there 
are at least three instances in which changes in the actions of EpDRF are associated with in vivo 
and/or in vitro alterations in airway reactivity to MCh, suggesting a functional relationship 
between the two. 
 Although LPS-treatment did not have an effect upon in vitro airway smooth muscle 
reactivity to MCh, it did have a profound effect upon in vitro epithelial bioelectric reactivity to 
MCh.  Biphasic concentration-response curves were generated in response to the EL- and IL-
application of MCh in both treatment groups.  Our results were consistent with the variable 
122 
electrophysiological effects produced by MCh in guinea-pig nasal epithelium (Suzuki et al., 
1999).  Suzuki et al. (1999) reported that MCh produced triphasic Isc responses:  a transient 
increase followed by a small decrease and then finally a sustained increased.  The authors 
concluded that these changes were brought about by alterations in Cl! secretion and amiloride-
sensitive Na+ transport (Suzuki et al., 1999).  MCh, by binding to either, M1, M3, or M5 
muscarinic receptors increases cytosolic Ca 2+ by coupling Gq-proteins (Janssen et al., 1998).  
Ca2+ in turn is capable of activating Ca2+-activated Cl! channels and/or Ca2+-activated K+ 
channels (Somlyo and Somlyo, 1994) which could subsequently alter the Vms.  In addition, the 
activation of M2 and M4 muscarinic receptors can open nonselective cation channels and inhibit 
current flow through Ca2+ channels and Ca2+-activated K+ channels by coupling Gi-coupled 
proteins (Roux et al., 1998).  The activation of more than one channel was most likely 
responsible for these biphasic electrical responses, and it is not certain which muscarinic receptor 
subtypes were initiating these responses.  M1, M2, and M3 muscarinic receptors have been 
localized in guinea-pig lung (Mak and Barnes, 1990), and in the future it may be useful to repeat 
these experiments in the presence of selective, muscarinic receptor antagonists.  The muscarinic 
receptors which were mediating these responses seem to be localized to the basolateral surface of 
the epithelium since MCh was more potent when added to the EL surface of the trachea.  Thus, 
there seem to be two types of muscarinic epithelial receptors which promote opposite electrical 
responses in the guinea-pig tracheal epithelium.  The high affinity receptor initiates 
hyperpolarization while the low affinity receptor mediates depolarization, and LPS-treatment 
seems to selectively alter the function of the high affinity receptor. 
 Since LPS was used as a tool to alter the basal bioelectric properties of guinea-pig 
tracheal epithelium, the results of this study have implications with respect to certain 
pathophysiological conditions in which LPS is involved, such as sepsis, ARDS, as well as gram-
negative pulmonary infections.  Our study has shown that LPS-treatment alters the actions of 
EpDRF on the airway smooth muscle, and this may potentially be happening under a variety of 
LPS-induced disease states.  At present, EpDRF’s only known function is to relax the airway 
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smooth muscle; however, it may be an important mediator of other unknown, physiological 
functions.  That is, these other potential functions of EpDRF may be altered in such a way by 
LPS that it contributes to the disease process.  EpDRF may, when present at high or low levels, 
be directly toxic to various cell types such that it inhibits their normal function or enhances the 
release of toxic substances from cells.  Conversely, high or low levels of EpDRF may protect 
cells from the insulting effects of LPS in such a way as to prevent further damage. 
 In conclusion, the results of this study suggest that the effects of EpDRF on the airway 
smooth muscle are associated with changes in the electrical activity of the airway epithelium; 
however, there is not always a direct correlation between the two events.  In addition, this study 
has shown that perturbations in the effects of EpDRF are associated with changes in airway 




 The initial reports by Raeburn and Fedan (1989), Dortch-Carnes et al. (1999), and Fedan 
et al. (1999), suggesting that the synthesis, release, and/or effects of EpDRF were functionally 
linked to the electrical activity of the airway epithelium, have been confirmed by the further 
characterization of the airway epithelial bioelectric mechanisms associated with the effects of 
EpDRF in this study. 
 Fedan et al. (1999) previously reported that apical Na+ channels are involved in 
hypertonicity-induced smooth muscle relaxation via EpDRF, and this study has shown that these 
channels are also involved in the epithelial bioelectric response to elevated mucosal tonicity.  
These data suggest that the mechanical and bioelectric events are functionally linked; however, 
the exact role of these channels in mediating these responses is unclear.  Despite the fact that 
inhibitors of basolateral Na+-K+-2Cl! cotransporters, basolateral Na+-K+-ATPases, and apical Cl! 
channels altered the response to elevated mucosal tonicity, their effects were different, in some 
respects, from their actions on EpDRF-induced smooth muscle relaxation, which makes their 
overall role in these two responses difficult to discern. 
 This study has also demonstrated that perturbations in the basal electrical activity of the 
epithelium following LPS-treatment are associated with alterations in EpDRF-induced smooth 
muscle relaxation and its associated bioelectric events as well as airway reactivity.  This further 
supports the notion that the synthesis, release, and/or effects of EpDRF are linked to the 
electrical activity of the epithelium.  Interestingly, the results seen with LPS have reinforced the 
importance of amiloride-sensitive Na+ channels in mediating EpDRF-induced smooth muscle 
relaxation since LPS-induced changes in epithelial electrophysiology appear to be due alterations 
in these Na+ channels.  At the most fundamental level, apical Na+ channels may control airway 





 The two, separate studies contained within this project have provided the groundwork for 
a more thorough investigation of the airway epithelial bioelectric mechanisms associated with 
the effects of EpDRF in guinea-pig isolated trachea.  In fact, this study has left many loose ends 
which could be tied up with future experiments. 
 First, the effects of other hypertonic solutions (i.e., KCl, sucrose, urea, etc.), on epithelial 
bioelectric responses could be examined to determine if the epithelial response to hypertonic 
challenge is osmolyte dependent.  In addition, the effects of ion channel and transporter 
inhibitors on the epithelium’s bioelectric response to these hypertonic solutions could also be 
investigated for similar reasons.  In addition, these experiments could be repeated with LPS-
treated tissue to determine how this would influence the epithelial bioelectric responses to 
hypertonic solution. 
 Since it appears that alterations in amiloride-sensitive Na+ channels play a significant role 
in the hyperpolarization of the Vms following LPS-treatment, it would be interesting to examine 
these channels at the molecular level.  Channel protein or mRNA levels may change after LPS-
treatment which could be examined by Western and Northern blotting, respectively.  In addition, 
channel kinetics could be investigated through patch clamping.  The effect of amiloride and the 
other ion channel and transporter inhibitors on LPS-induced alterations in EpDRF-induced 
smooth muscle relaxation could also be investigated.  Finally, it would be interesting to see if 
epithelial depolarization is potentiated following LPS-treatment in response to the IL-application 
of D-mannitol, urea, and KCl, which could shed more light on the relationship between epithelial 
depolarization and the degree of EpDRF-induced smooth muscle relaxation. 
 Although it was not a major focus of this study, it would be extremely interesting to 
distinguish which epithelial muscarinic receptor subtypes were responsible for the biphasic 
electrical responses to MCh, not only in saline-treated animals but also in those treated with LPS.  
The use of selective, muscarinic receptor antagonists could give insight into the receptor 
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subtypes involved.  In addition, it would be of interest to distinguish why LPS-treatment only 
affects the bioelectric reactivity of some muscarinic receptor subtypes and not others.  This could 
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